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Leptin is a hormone predominantly secreted by white adipose tissue which 
was initially believed to be solely a metabolic factor. Recent publications 
showed that leptin also played a role in inflammation and vascular disease, to 
which Sca-1+ vascular progenitor cells within the vessel wall may contribute. 
However, the effect of leptin on vascular progenitor cells remains unknown.  
In the present study, we sought to elucidate the effect of leptin on Sca-1+ 
progenitor cells and neointimal formation, and to understand the underlying 
mechanisms.  
Sca-1+ progenitor cells from the vessel wall of C57BL/6J (Lepr+/+) and db/db 
(Lepr-/-) mice were cultured and purified with microbeads. The migration of 
Sca-1+ progenitor cells in vitro derived from Lepr+/+ mice was markedly 
induced by leptin. Western blotting and kinase assays revealed that leptin 
induced phosphorylation of STAT3, ERK1/2, FAK, and Rac1/Cdc42. 
Guide-wire injury of the femoral artery was performed in wild-type mice with 
neointimal development in a time-dependent manner. An increased 
expression of leptin in both injured vessels and serum was observed at 24 
hours post-surgery. Red fluorescent protein (RFP) labelled-Sca-1+ progenitor 
cells in Matrigel were applied to the adventitia of the injured femoral artery, 
RFP+ cells were observed in the intima at 24 hours post-surgery, which 
significantly enhanced neointimal lesions at 2 weeks. This increase in 
neointimal lesions was reduced by pre-treatment of Sca-1+ cells with 
CYT-354 (leptin antagonist). Moreover, guide-wire injury could only induce 
minor neointima in Lepr-/- mice at 2 and 4 weeks post-surgery. However, 
transplantation of Lepr+/+ Sca-1+ progenitor cells into the adventitial side of the 
injured femoral arteries of Lepr-/- mice significantly enhanced the neointimal 
formation. 
In summary, upregulation of leptin levels in both the vessel wall and the 
circulation following vessel injury resulted in the migration of Sca-1+ 
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progenitor cells, which enhanced neointimal formation via leptin 
receptor-dependent STAT3- Rac1/Cdc42-ERK-FAK pathways. 
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1.1. Vascular System 
1.1.1. The Definition of Blood Vessels 
The blood vessels are the conduits which transport blood throughout the 
whole human body. There are five types of blood vessels: the arteries, which 
deliver the blood away from the heart; the arterioles, which extend and branch 
the arteries to capillaries; the capillaries, which carry out the exchange of 
oxygen, liquid and chemical compounds between the blood and tissues; the 
venules, which enable blood return from the capillaries to larger veins; the 
veins, which transport blood back to heart. The schematic representation of 
five types of blood vessels is listed below (Figure 1.1). 
 
Figure 1.1. The structure of blood vessels. The scheme demonstrates the 
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structure of artery, arteriole, capillaries, venule and vein. The composition of 
vessel wall varies from different size of vessels. Large vessels such as 
arteries and veins have multiple layers of cellular and extracellular materials 
while capillaries only occupy a loose covering of pericytes (Cleaver & Melton, 
2003). 
 
1.1.2. The Structure of Vessels 
Both arteries and veins have three layers in the vessel walls, which are 
named tunica intima, tunica media and tunica adventitia from the inside of the 
vessel walls outwards. Although arteries and veins have a similar composition 
of vessel walls, the middle layer, tunica media, is thicker in the arteries than it 
is in the veins, particular in large arteries.  
The tunica intima, or intima for short, is the innermost layer of artery or vein, 
which is also the thinnest layer of the vessel wall. The intima consists of a 
single layer of endothelial cells (ECs) supported by an internal elastic lamina. 
Endothelium is a fine, transparent, colorless structure which is in direct 
contact with the blood flow. The endothelial layer can be easily observed 
when stained with PECAM-1 (CD31), VE-Cadherin (CD144) or silver nitrate. 
Unlike other four types of vessels, capillaries only have tunica intima, the 
ultra-thin structure of which enable the exchange of nutrients and gases in the 
capillary beds, suggesting the importance of the endothelium throughout the 
entire vascular system.  
The tunica media, or media for short, is the middle layer of an artery or vein, 
which is between the tunica intima and tunica adventitia. Media is mostly 
composed of smooth muscle cells (SMCs) and elastic tissues. The media 
layer is much thicker in the large arteries than it is in the veins. The thicker 
media helps regulate the constriction and dilation of arteries, controlling the 
blood supply and blood pressure in the circulation. When SMCs in the media 
are stimulated by certain chemokines and factors, they contract and narrow 
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the vessel. This process is named vasoconstriction. On the contrary, 
vasodilation is the opposite term of vasoconstriction caused by the relaxation 
of the SMCs, decreasing blood flow and blood pressure. SMCs are usually 
identified by staining with alpha-smooth muscle actin (α-SMA), calponin, 
myocardin and smooth muscle myosin heavy chain (SMMHC), 
The tunica adventitia or, adventitia for short, is the outermost layer of a 
vessel which is mainly composed of collagen and elastic fibers. The adventitia 
protects the vessels from overexpansion. The vessels are supported by 
external elastic lamina and collagen via anchoring the blood vessels to 
nearby organs and tissues. The adventitia of large blood vessels also 
contains nerves and nutrient capillaries (vasa vasorum) which provide the 
nutrition and oxygen to the adventitia. On the contrary, the media and intima 




















1.2.1. The Definition of Atherosclerosis 
Arteriosclerosis is the principal cause of heart attack, stroke, and gangrene of 
the extremities, remains a major contributor to the morbidity and mortality in 
the Western world (R. Ross & Glomset, 1976). Various factors, such as 
genetic polymorphism, hypercholesterolemia, modified lipoproteins, 
hypertension, diabetes mellitus, autoimmune responses, infections and 
smoking, were related to the development of cardiovascular diseases. 
However, the precise etiology and pathogenesis of these vascular diseases 
remains to be elucidated. Arteriosclerosis is characterized by the hyperplasia 
or hypertrophy of smooth muscle cells (SMCs) and accumulation of matrix 
protein in the intima and media with or without lipid deposition, both of which 
results in thickening and stiffness of the arterial wall (Stary, 1989). 
Arteriosclerosis is characterized into four subgroups: (spontaneous) 
atherosclerosis, accelerated arteriosclerosis (namely, transplant 
arteriosclerosis), restenosis after percutaneous transluminal coronary 
angioplasty and vein graft atherosclerosis (Wick, Kloflach, & Xu, 2004). The 
development of atherosclerosis is a very slow process, over a period of years 
even without any symptoms. In human, typical atherosclerosis undergoes 
three stages (Figure 1.2).  
Early stage of atherosclerosis is associated with the adherence of 
circulating white blood cells (monocytes). Endothelial cells (ECs) are 
activated under certain circumstances such as hypertension, vascular injury 
and hypercholesterolemia. Meanwhile, the permeability of endothelium and 
the composition of extracellular matrix in the sub-endothelium layer have 
been altered, leading to the invasion and oxidation of low-density lipoprotein 
(LDL) particles from blood to endothelium. Initial lesions of endothelium result 
in the inflammatory response, which recruits the monocytes from the blood. 
Activated endothelial cells are capable of secreting various chemokines, 
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leading to the migration of additional leukocytes and the maturation of the 
monocytes coming from the circulation into macrophages. These 
macrophage as well as white blood cells infiltrate into the lesion, uptake the 
lipid and get trapped in the vessel wall to produce foam cells subsequently. 
Foam cells together with T lymphocytes constitute the fatty streak which is the 
earliest sign of atherosclerosis.  
The second stage of atherosclerosis includes the migration of smooth 
muscle cells (SMCs) from media to the intima, prior to the proliferation of 
smooth muscle cells and secretion of extracellular matrix macromolecules 
such as collagen, elastin and proteoglycans. Smooth muscle cells and 
macrophages undergo apoptosis during the process of plaque formation, 
leading to the release of lipids in plaque’s central zone. In typical 
atherosclerosis, three different areas can be identified by a different 
proportion of smooth muscle cells, macrophages, matrix and inflammatory 
cells: fibrous cap, lipid zone and basal zone. In a more advanced process, 
cholesterol crystal cores and microvessels are the biomarkers for 
atheromatous plaques. The final stage of atherosclerosis involves in some 
serious complications such as thrombosis, plaque rupture, calcification and 






Figure 1.2. Stages of development of atherosclerosis (Libby, Ridker, & 
Hansson, 2011). a, A normal artery contains three layers. b, The initial stage 
of atherosclerosis is associated with adhesion of leukocytes to the activated 
ECs, migration of the attached leukocytes toward intima, and maturation of 
monocytes into macrophages which uptake lipid to produce foam cells. c, 
Lesion progression includes the proliferation of resident intima SMCs and 
media-derived SMCs. Plaque SMCs and macrophages can undergo 
apoptosis at the late stage of atherosclerosis, leading to a lipid or necrotic 
core. Cholesterol crystals and microvessels can be observed in an  
advanced plaque. d, The final stage of atherosclerosis comes to thrombosis, 









1.3. Adult Cells in Atherosclerosis  
1.3.1. Endothelial Cells Dysfunction 
Vascular endothelial cells cover entire cardiovascular system from the heart 
to small capillaries. The endothelium is regarded as a semi-selective barrier 
and provides a non-thrombogenic surface. The dysfunction of endothelium is 
treated as a biomarker for various vascular diseases, which is often related to 
the early stage of atherosclerosis. The impaired endothelial function can be 
caused by hypertension, diabetes, hypercholesterolemia, etc. The endothelial 
lining can secret various autocoid factors which have an effect on other types 
of cells in vessel wall such as smooth muscle cells and pericytes, and in blood 
such as platelets and leukocytes. The endothelial isoform of NO synthase 
(eNOS) was one of the factors which were also shown to play important role 
in vascular remodeling (Palmer, Ashton, & Moncada, 1988). The basal level 
production of NO by endothelial cells is crucial for the homeostasis of the 
vascular system. Under pathologic situation, once NO is produced by eNOS, 
it can rapidly distribute through cell membranes as a paracrine factor. This 
secreted NO can have an effect on adjacent smooth muscle cells, circulating 
blood platelets and leukocytes by activating soluble guanylate cyclase, which 
catalyzes GTP to cGMP. NO may also be mediated by S-nitrosylation to alter 
the function of proteins reversely. The target protein of S-nitrosylation has 
been proved to regulate important cellular processes such as cell proliferation, 
apoptosis and ion channel activity (Gimbrone & García-Cardeña, 2016).  
In the atherosclerotic region of the arteries, endothelium can be activated 
by various proinflammatory agonists such as interleukin-1 (IL-1), tumor 
necrosis factor (TNF), endotoxin, oxidized lipoprotein (ox-LDL) as well as 
biomechanical stimulation. The appearance of these agonists leads to a 
coordinated program of genetic regulation via nuclear factor-κB (NF-κB) 
within endothelial cells. Adhesion molecules such as vascular cell adhesion 
melocule-1 (VCAM-1) and secreted and membrane-associated chemokines 
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such as monocyte chemoattractant protein (MCP-1) can be upregulated 
subsequently, leading to the selective recruitment of monocytes and 
lymphocyte in the subendothelial area (Pober et al., 1986). The activated 
endothelial cells, smooth muscle cells, monocyte, macrophage and 
lymphocytes together result in the production of a complex mixture of 
paracrine cytokines and growth factors within the vessel wall, fostering the 
progression of atherosclerosis (Figure1.3).  
 
 
Figure 1.3. Endothelial proinflammatory activation (Gimbrone & 
García-Cardeña, 2016). In atherosclerotic regions, IL-1, TNF, ox-LDL and 
AGE secreted by leukocytes as well as MCP-1, IL-8, etc. from the disturbed 
blood flow activate the endothelium, followed by the activation of NF-κB in the 
nuclei, leading to a coordinated program of genetic regulation (VCAM-1, 
MCP-1, TF, vWF and PAI-1). This upregulation enhances the recruitment of 
leukocytes. The recruited leukocytes, together with activated endothelial cells, 
smooth muscle cell, and lymphocytes produce a complex paracrine milieu of 
28 
 
chemokines within the vessel wall, accelerating the process of 
atherosclerosis. 
 
1.3.2. Leukocytes Recruitment 
Following vascular injury and endothelial dysfunction, recruitment of 
leukocytes to the injured site is of great importance. Subsequent changes of 
adhesion events in endothelial cells ensure that the leukocytes leave the 
bloodstream and only stay at the damaged site (Ley, Laudanna, Cybulsky, & 
Nourshargh, 2007). Three groups of adhesion molecules can be defined 
between the attachment of leukocyte and endothelial cells: (1) Selectins are 
three carbohydrate-recognizing molecules with E-selectin expressing on the 
activated endothelium, P-selectin expressing on platelets and the 
endothelium, and L-selectin expressing on leukocytes (Vestweber, 1992); (2) 
Integrins are heterodimers with an α- and a β-chain which can recognize 
various ligands. Integrins need conformational changes to acquire fully 
functional adhesion ability. Leukocytes express integrins such as CD11 and 
CD18 (Hynes, 1992); (3) the immunoglobulin superfamily are the major 
ligands involved in leukocytes adhesion such as intercellular cell adhesion 
molecules (ICAM) 1-5, vascular adhesion molecule-1 (VCAM-1), platelet 
endothelial cell adhesion molecule-1 (PECAM-1) and junctional adhesion 
molecules (JAMs) which are expressed on endothelial cells (Langer & 
Chavakis, 2009).  
The initial process of recruitment of leukocyte involves in the 
selectin-mediated interaction between leukocytes and endothelial cells. After 
the rolling or tethering of leukocytes on the luminal endothelial surface, 
leukocytes are capable of sensing the endothelial surface-bound chemokines, 
which are induced by proinflammatory factors (Charo & Ransohoff, 2006). 
Four groups of chemokines are defined according to the presence or absence 
of intervening amino acids between the first two N-terminal cysteine residues 
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which are CC, CXC, CX3C and C chemokines. Binding to the receptors of 
these chemokines on leukocytes leads to the activation of leukocytes’ integrin, 
resulting in firm adhesion of leukocytes (Arfors et al., 1987). Besides the 
crosstalk between endothelium and leukocytes, platelet also plays a crucial 
role in the recruitment of leukocytes. Upon vascular injury, platelets aggregate 
in the inflammatory area and secret potent inflammatory and mitogenic 
substances which can significantly enhance the adhesion of endothelial cells 
and transmigration of leukocytes. A variety of chemokines such as stromal 
cell-derived factor 1 (SDF-1) can be released by platelets, which enable the 
activation of integrin of leukocytes and recruit more circulating leukocytes to 
the injured endothelium (Bleul, Fuhlbrigge, Casasnovas, Aiuti, & Springer, 
1996). The interaction between platelets, endothelium and leukocytes 
mediated by P-selection on platelets and Mac-1 on leukocytes also 
significantly enhance the recruitment of leukocytes (Simon et al., 2000). In 
summary, the role of non-inflammatory cells such as platelets can also 
participate in leukocytes recruitment.    
 
1.3.2.1. T Cell Infiltration 
Recent studies showed that T lymphocytes could be detected both in early 
fibrous plaques and in more advance ones. The class II MHC antigen, 
HLA-DR which is inducible by T cell products are found expressing on smooth 
muscle cells in neointima, indicating that T lymphocytes may participate in 
atherogenesis (G. Hansson et al., 1988). Activated T cells are capable of 
releasing a series of angiogenic factors including vascular endothelial growth 
factor (VEGF) and stimulating early recruitment of leukocytes (G. K. Hansson, 
2001). CD4 deficient mice showed an attenuated ability of angiogenesis in a 
hindlimb ischemia mouse model. What is more, inflammation in CD4 deficient 
mice was greatly impaired versus wild-type mice (Stabile et al., 2003). 
Immunohistochemistry staining of fatty streak of apoE-/- mice revealed that 
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CD4+ T cells were prominent in the fibrous cap and subendothelial area, 
compared to CD8+ T cells. CD25 subunit of IL2 which is a marker of activated 
T cells was also discovered in CD4+-rich area. Taken together, activated CD4+ 
T cells can participate in the formation of atherosclerosis (Xinghua Zhou, 
Stemme, & Hansson, 1996).   
 
1.3.2.2. Monocyte / Macrophage Recruitment  
Monocytes originate from the progenitor cells in bone marrow and migrate 
from the bloodstream to peripheral tissue. Upon inflammation or other 
pathologic situation, monocytes can give rise to macrophages and dendritic 
cells (Swirski et al., 2009). In the early stage of atherosclerosis, prominent 
monocytes were found attached to the endothelium of atherosclerotic area of 
the arteries (Figure 1.4), which is also a hallmark of atherosclerosis 
(Bobryshev, 2006).  
According to the expression of chemokine receptor and specific surface 
markers, monocytes are divided into two main subsets. Monocytes which 
express high level of CC-chemokine receptor 2 (CCR2) but low levels of 
CX3C-chemokine receptor 1 (CX3CR1) are defined as inflammatory 
monocytes. Inflammatory monocytes occupy 2-5% of circulating leukocytes 
and can be rapidly recruited to the inflammatory areas (Serbina, Jia, Hohl, & 
Pamer, 2008). CC-chemokine ligand 2 (CCL2 or MCP1) and CCL7 (MCP3) 
are the ligands of CCR2 which mediates the recruitment of monocytes (Tsou 
et al., 2007). The expression of CCL2 in serum and tissues can be 
upregulated when proinflammatory cytokines or innate immune receptors are 
activated (Brown et al., 1994). CCL7 can be also induced during the infection 
in mice. Deletion of either CCL2 or CCL7 greatly decreased the recruitment of 
monocytes (Jia et al., 2008). However, the mechanism of how CCL2 and 
CCL7 work on recruitment remains unclear. CCL8 and 12 also bind to CCR2 
but deletion of these genes does not affect the monocyte trafficking (Tsou et 
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al., 2007). Second major subsets of monocytes, also named LY6Clow  
express high levels of CX3CR1 and low levels of CCR2 and can adhere to 
and migrate along the luminal surface of endothelial cells (Auffray et al., 
2007). CX3C-chemokine ligand 1 (CX3CL1) is the major ligand for this type of 
monocytes. Deletion of CX3CL1 abolished patrolling by LY6Clow monocytes 
and also diminished the recruitment of inflammatory monocytes (Auffray et al., 
2009). 
Monocytes migrate to arterial intima by penetrating through the 
endothelium. Once monocytes anchored to the endothelium of injured blood 
vessels, they undergo differentiation (Zernecke & Weber, 2005). During the 
differentiation of monocytes towards macrophages, CD68 is continuously 
expressed in the lysosomes of macrophages. M-CSF, which is the major 
regulator of differentiation of macrophages, was also detected in 
atherosclerotic lesions (Bobryshev, 2006). Furthermore, both macrophage 
populations exist in early atherosclerotic lesions at the same time. Most of 
macrophages with lipids in the cytoplasm are capable of transforming into 
foam cells, whereas the rest of the macrophages cannot become foam cells 
in the atherosclerotic area. Their functions, however, remain unknown. 
Besides the macrophages, monocytes can also differentiate into dendritic 
cells which are known as the most potent antigen-presenting cells (Bobryshev, 
2005).  
In more advanced atherosclerosis, only few macrophages and dendritic 
cells are detected in the fibrous caps (Bobryshev, Cherian, Inder, & Lord, 
1999). The presence of dendritic cells can be observed mostly in the area of 
neovascularization, indicating the ingrowths of vasa vasorum from adventitia 
to intima (Bobryshev et al., 1999). In these neovascularization zones, 
E-selectin and ICAM-1 are highly expressed within the neovasculature. The 
expression of both factors mentioned above has been shown to be related to 





Figure 1.4. Recruitment of monocytes. Hyperlipidemia enhances the 
number of LY6Chi monocytes and LY6Clow patrolling monocytes, both of which 
use various chemokine-chemokine receptor pairs for the infiltration to the 
intima. This process is promoted by endothelial adhesion molecules, such as 
ICAM1 and VCAM, followed by the differentiation into macrophages or 
dendritic cells (Moore, Sheedy, & Fisher, 2013). 
 
1.3.3. Smooth Muscle Cells 
Vascular smooth muscle cell (VSMC) is a particular type of smooth muscle 
which occupies the majority of the vessel wall. VSMC in normal arteries 
express contractile smooth muscle cell markers such as smooth muscle cell 
myosin heavy chain (MYH11), SM22α and smoothelin. Upon atherosclerosis, 
VSMC undergoes phenotypic switching to synthetic phenotypic, expressing 
markers such as S100A4, CX43, etc (Alexander & Owens, 2012). In some 
cases, VSMC can also occupy macrophage markers such as CD68. The 
phenotypic switching has been long-considered as an important factor in 
atherosclerosis, but its underlying mechanisms and biological effect remain 
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unclear. The origins of the majority of intimal smooth muscle cells within 
atherosclerotic lesions are commonly believed derived from medial smooth 
muscle cells which undergo phenotypic switching. These smooth muscle cells 
migrate into the intima, followed by the proliferation on site, secretion of 
extracellular matrix and participate in the formation of fibrous cap (Russell 
Ross, 1993). The underlying mechanism of phenotypic switching is complex. 
Myocardin+/- mice on apoE-/- backgroud showed an increased atherosclerosis 
with enhanced recruitment of macrophage compared to that in Myocardin+/+ 
mice. Loss of myocardin greatly upregulated a series of pathways which were 
involved in inflammation and facilitated the phenotypic change from VSMC to 
a macrophage-like phenotype (Ackers-Johnson et al., 2015). Kruppel-like 
factor 4 (KLF4) has been shown necessary for phenotypic transition of VSMC 
in vitro in response to platelet-derived growth factor-BB (PDGF-BB). 
Knockout of KLF4 did not affect the total number of VSMC but significantly 
reduced the number of macrophage-like and mesenchymal stem cell-like 
cells, indicating the important role of KLF4 in smooth muscle cell transition 
(Shankman et al., 2015) (Figure 1.5). Meanwhile, several studies proposed 
alternative origins of VSMC-like cells in atherosclerotic lesions. For instance, 
Hu et al proposed that Sca-1+ progenitor cells may contribute to neointimal 
formation after vascular injury (Y. Hu et al., 2004). Adventitial pericytes 
(Tigges, Komatsu, & Stallcup, 2013) and adventitial fibroblasts (Coen, 
Gabbiani, & Bochaton-Piallat, 2011) may also be the potential sources for 
VSMC-like cells in atherosclerotic lesions.  
VSMC is also responsible for producing extracellular matrix within the 
vessel walls during the initial stage of atherosclerosis, which in turn affects 
the lipid content and proliferative index in the plaque. Similar to macrophage, 
smooth muscle cells can also express various receptors for lipid uptake to 
form foam-like cells. Similar to endothelial, smooth muscle cells can express 
endothelial-like adhesion molecules such as vascular cell adhesion 
molecule-1 and intercellular adhesion molecule-1, both of which can trap 
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monocytes and lymphocytes within the vessel wall. Smooth muscle cells can 
also secrete transforming growth factor-β, IFNγ, and MCP-1, all of which are 
proved to participate in atherosclerosis (Doran, Meller, & McNamara, 2008). 
 
 
Figure 1.5. Schematic figure of the latest summary of the identification 
and origins of vascular smooth muscle cells in atherosclerotic lesions. 
The sold lines represent well-established pathways which contribute to 
atherosclerosis. Dotted lines or lines with “?” represent hypothesized 










1.4. Stem Cells in Atherosclerosis 
Stem cells are a group of undifferentiated cells which can differentiate into 
specialized cells. Stem cells are distinguished from other cells by two 
important features. First, self-renewal: stem cells are capable of producing 
more stem cells through mitosis and maintain their undifferentiated state. 
Second, potency: under certain conditions, stem cells can be induced into a 
specialized type of cells with particular functions (Basics, 2009) (Figure 1.6).  
In mammals, there are two basic types of stem cells: adult stem cells and 
embryonic stem cells. Embryonic stem cells come from very early stage when 
a zygote begins to divide. Embryonic stem cells are able to differentiate into 
any kind of cells. On the other hand, adult stem cells have a limited 
multipotency and can only differentiate into limited type of cells (Basics, 2009). 
Vascular regeneration with the application of stem cells, which includes 
restoration of normal vascular structure and function, the reversal of vascular 
senescence and the growth of new blood vessels, may be a promising 
approach for the treatment of vascular diseases (Leeper, Hunter, & Cooke, 
2010). Stem/progenitor cells are able to differentiate into vascular cell 
lineages, which may contribute to the regenerative process and could be 





Figure 1.6. ESCs’ differentiation. Human embryonic stem cells are capable 
of giving rise to different cell types including liver cells, intestinal cells, 
pancreatic islet cells, blood cells and muscle cells (Meregalli, Farini, & 
Torrente, 2011). 
 
1.4.1. Embryonic Stem Cells 
Embryonic stem cells (ESCs) are pluripotent cells, which are derived from the 
inner cell mass of the blastocyst. Embryonic stem cells have the ability to 
differentiate into any cell type and can divide indefinitely to produce daughter 
cells both in vitro and in vivo (Rippon & Bishop, 2004).  
Various methods have been proposed for the differentiation of endothelial 
cells from embryonic stem cells. The mechanisms behind this have been 
studied in great detail (Luo, Wang, Wang, Xiao, & Xu, 2011). Bioengineered 
tissues are considered as a promising treatment in regenerative medicine. By 
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performing three-dimensional suspension culture and applying factors such 
as VEGF and 8-bromo-cAMP, stem cell-derived CD31+ cells, were 
successfully generated of, and were able to form microvascular networks 
(Masuda et al., 2015). Co-culture of CD31+ stem cell-derived cells with 
cardiomyocytes and dermal fibroblasts led to tube formation in cardiac cell 
sheets. This newly established method could be of great use for fabricating 
pre-vascularized cardiac cell sheet for grafting onto ischemic heart tissue or 
for preparation of a bioengineered heart on a scaffold (Masuda et al., 2015). 
To understand the mechanisms behind stem cell differentiation into 
endothelial cells, Wu et al. established a model to study epigenetic 
modification. They found that expression of histone demethylases KDM4A 
and KDM4C, which can bind to histones associated with Flk1 and 
VE-cadherin promoters, was upregulated during endothelial differentiation. 
Deletion of either KDM4A or KDM4C inhibited endothelial differentiation in 
murine embryonic stem cells in vitro and retarded blood vessel formation in 
zebrafish in vivo (Wu et al., 2015).  
Regarding differentiation of embryonic stem cells towards smooth muscle 
cell, there are a large number of reports about the mechanisms behind cell 
differentiation (Q. Xiao, Wang, Luo, & Xu, 2010). Recently, Wang et al (X. 
Wang, Karamariti, Simpson, Wang, & Xu, 2015) reported that the expression 
of dickkopf homolog 3 (DKK3) was essential for the expression of smooth 
muscle markers and myocardin at both the mRNA and protein levels during 
the differentiation of stem cell towards smooth muscle cells. Overexpression 
of DKK3 led to a subsequent upregulation of the markers mentioned 
previously. Further investigation indicated that DKK3 induced the activation of 
activating transcription factor 6 (ATF6), leading to the firm binding of ATF6 to 
the myocardin promoter and increasing its expression (X. Wang et al., 2015). 
These findings offered a novel mechanism by which DKK3 regulated stem 




1.4.2. Induced Pluripotent Stem Cells 
Unlike embryonic stem cells, induced pluripotent stem (iPS) cells are 
pluripotent stem cells which can be directly generated from adult cells. This 
technology was firstly developed by the Yamanaka’s group in 2006 via the 
application of four specific gene encoding transcription factors, Oct4, Sox2, 
cMyc and Klf4 in adult fibroblasts, which can be used to convert mature cells 
into pluripotent stem cells (Takahashi & Yamanaka, 2006) (Figure 1.7).  
Some studies then focused on the differentiation of iPS cells towards 
vascular lineages. Human iPS cells derived from patients with type 1 diabetes 
mellitus display similar differentiation efficiency when compared with iPS cells 
derived from healthy donors (Chan et al., 2015). These patient-derived iPS 
cells can differentiate into endothelial lineages expressing typical endothelial 
markers and with functional capabilities of lectin binding, acetylated low 
density lipoprotein uptake, tube formation in Matrigel and response to TNF-α. 
IPS-derived endothelial cells could undergo morphogenesis and assemble 
into 3D networks when cultured in engineered hyaluronic acid hydrogels or in 
response to low oxygen in vivo, and could incorporate into developing 
vasculature in zebrafish (Chan et al., 2015). Similar results were also 
obtained in another study where human iPS cells derived from somatic tissue 
could differentiate into both endothelial cells and pericytes which were fully 
functional both in vivo and in vitro (Orlova et al., 2014). 
To further investigate the mechanisms of iPS cell differentiation, Chen et al  
discovered that miR-199b was involved in endothelial differentiation (T. Chen 
et al., 2015). A step-wise increase in expression of miR-199 was detected 
during endothelial differentiation. Notably, miR-199b targeted the Notch ligand 
JAG1, resulting in VEGF transcriptional activation and secretion through the 
STAT3 transcription factor. Upon shRNA-mediated knockdown of the Notch 
ligand JAG1, the regulatory effect of miR-199b was ablated, and there was 
robust induction of STAT3 and VEGF during endothelial differentiation (T. 
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Chen et al., 2015). Using an in vitro tube formation assay and implanted 
Matrigel plugs in vivo, miR-199b was also shown to regulate VEGF 
expression and angiogenesis. MiR-199b can thus be said to play a novel role 
as a regulator of the phenotypic switch during vascular cell differentiation from 
iPS cells by regulating critical angiogenic signaling responses.  
 
 
Figure 1.7. Embryonic stem cells and induced pluripotent stem cells can 
give rise to vascular lineages. ESCs can differentiate into endothelial cells 
and smooth muscle cells via multiple signaling pathways (Li Zhang & Qingbo 
Xu, 2014). For somatic cells, they can be reprogrammed and re-differentiated 
into vascular lineages. 
 
1.4.3. Adult Stem Cells 
Adult stem cells are undifferentiated cells found among the differentiated cells 
in tissue or organs. They are also known as non-embryonic stem cells or 
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somatic stem cells, which have the ability to divide indefinitely and 
differentiate into all cell types of the organ where they locate (Toma et al., 
2001). Several signaling pathways are involved maintaining their abilities of 
self-renewal and potency, such as Notch, Wnt and TGFβ (Beachy, Karhadkar, 
& Berman, 2004; Dontu et al., 2004). Adult stem cells can be isolated from 
many regions including bone, bone marrows, blood and adipose tissues. 
Other adult tissue sources include but not limited to nose, muscle, liver, skin, 
brain, and the retina of eye (Kumar, 2008).  
 
1.4.3.1. Mesenchymal Stem Cells  
Mesenchymal stem cells are a group of multipotent stromal cells which can 
differentiate into various types of cells, such as osteoblasts, chondrocytes, 
myocytes and adipocytes (Abedin, Tintut, & Demer, 2004) (Figure 1.8). 
Mesenchymal stem cells can be isolated from a number of different tissues 
including umbilical cord, bone marrow, and adipose tissue (Ding, Shyu, & Lin, 
2011). The properties of these cells vary from tissue to tissue. For instance, 
cells isolated from adult bone marrow display a stable phenotype, including 
SH2, SH3, CD29, CD44, CD71, CD90, CD105, CD106, CD120a, CD124 
expression and are capable of differentiating into adipocytic, chondrocytic, or 
osteocytic lineages (Pittenger et al., 1999). Understanding the mechanisms 
behind cell differentiation, migration, mobilization and homing will be of great 
help in the future clinical application when these cells are regarded as 
treatments for vascular diseases. 
Due to their easy access and relative abundance compared to other kinds 
of mesenchymal stem cells, adipose tissue stromal cells have recently 
become a popular cell type for stem cell research (Preda et al., 2014). 
Adipose tissue is a highly complex mixture which consists of more than 90% 
tissue volume adipocytes and stromal vascular fraction (SVF) (Weisberg et al., 
2003). SVF is a heterogeneous cell population with adipose derived stem 
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cells (ADSCs) inside. ADSCs isolated from human subcutaneous adipose 
tissue displayed specific antigenic phenotype: CD34+, CD13+, CD45–, CD14–, 
CD144– and CD31- with the capacity of giving rise to adipocytes or endothelial 
cells in vitro (Planat-Benard et al., 2004). Specific ADSCs which expressed 
Sca-1+, CD34+, CD45– and CD31+ were capable of differentiating into white 
adipose tissue in mice (W. Tang et al., 2008). One article also demonstrated 
that the proliferative ability of CD34+ ADSCs could be maintained for 20 
weeks in vitro (Yoshimura et al., 2006), whereas CD34- ADSCs were more 
plastic but less proliferative (M Bailey, Kapur, & J Katz, 2010).  
The role of ADSCs in vascular remodeling was heavily studied. Injection of 
allogeneic abdominal adipose-derived stem cells, either with or without 
transfection with plasmid-VEGF165, provided a protective role in a rabbit 
model of critical hindlimb ischemia. These adipose-derived stem cells 
increased arteriolar density and protection against ischemia-induced muscle 
lesions (Olea et al., 2015). Although cell culture provides a good approach for 
studying the differentiation, migration, and proliferation of ADSCs in vitro, it is 
more relevant to study ADSCs in their biological context in vivo. SVF is 
obtained by collagenase digestion of adipose tissue and centrifugation to 
remove mature adipocytes. Joe et al. purified Lin-Sca-1+CD34+ cells from 
SVF from white adipose tissue in GFP mice by FACS (Joe, Yi, Even, Vogl, & 
Rossi, 2009). The cells were then transplanted with Matrigel into wild-type 
mice. As a result, adipocyte progenitor cells were able to form mature 
unilocular and multilocular adipocytes with GFP expression. In another 
research, Miranvile et al. reported that CD31-CD34+ SVF cells could 
differentiate into endothelial cells, express CD31 markers and develop 
vascular structure in Matrigel in response to the treatment with VEGF, 
suggesting adipose derived stem cells may participate in an angiogenic 
process (Miranville et al., 2004). 
Though mesenchymal stem cells have a therapeutic benefit, recent studies 
suggested they may also play a role in the pathology of aortic valve disease 
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(Wirrig & Yutzey, 2014). One potential mechanism is about the regulation of 
endothelial-to-mesenchymal transitions (EMT) during stem cell differentiation. 
The endocardial endothelial cells undergo EMT, producing mesenchymal 
valve progenitor cells in hyaluronan-rich extracellular matrix. Sox9 is required 
for the proliferation of endocardial cushion and the expansion of valve 
progenitor cells. Deletion of Sox9, which is a valve progenitor marker, resulted 
in the calcification of aortic valve in the mouse model, illustrating a potential 
role of these progenitor cells in heart valve diseases, the mechanism of which 
could be useful in the future treatments (Wirrig & Yutzey, 2014). Besides 
adipose tissue, bone marrow, heart valve mentioned above, it seems likely 
that further sources of mesenchymal stem cells exist.   
 
 
Figure 1.8. MSC differentiation. Mesenchymal stem cells can be isolated 
from various tissues, such as umbilical cord, bone marrow, cartilage, muscle, 
and adipose tissue. Cells from different tissues differ in properties including 
cell surface markers expressed and differentiation abilities. Mesenchymal 
stem cells can give rise to many cell lineages, such as osteocytes, 
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chondrocytes, and fibroblasts. Under certain circumstances, mesenchymal 
stem cells in the circulation can migrate to an injured area, differentiating into 
endothelial cells to repair damage-triggering angiogenesis and smooth 
muscle cells (SMC) which potentially form neointimal lesions. Schematic 
summary of involved molecules and transcription factors during the 
differentiation of mesenchymal stem cells are shown above (Karantalis & 
Hare, 2015).  
 
1.4.3.2. Hematopoietic Stem Cells 
Hematopoietic stem cells are a group of stem/progenitor cells which can give 
rise to both myeloid and lymphoid lineages of blood cells. They are found in 
the largest quantities in bone marrow but also exist in peripheral and umbilical 
cord blood. The physiological and pathological state of hematopoietic stem 
cells is vital for vascular regeneration (Mathur & Martin, 2004). ApoE-/- mice 
with monocytosis and atherosclerosis showed enhanced expansion of these 
cells associated with increased surface expression of a common β subunit of 
granulocyte macrophage colony-stimulating factor/interleukin-3 receptor (M. 
Wang et al., 2014). Transplantation of apoE-/- bone marrow into LDLR-/- mice 
resulted in an increased level of granulocyte macrophage colony-stimulating 
factor on stem cells and innate response activator B cells in spleen, which led 
to the expansion of hematopoietic stem cells. Therefore, granulocyte 
macrophage colony-stimulating factor could contribute to monocytosis and 
increased damaged macrophage content, affecting atherosclerosis plaque 
stabilization (M. Wang et al., 2014). Scavenger receptor type B1, as a high 
density lipoprotein receptor, was found on murine hematopoietic stem cells. 
The expression of SR-BI was related to the anti-proliferative effects of HDL on 
hematopoietic stem cells. SR-BI-/- bone marrow transplanted LDLR-/- mice 
induced reconstruction of white blood cells, production of inflammatory cells 
and plaque development. Moreover, HDL level was negatively correlated with 
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the proliferation and differentiation of hematopoietic stem cells in the 
circulation, which was associated with atherosclerosis progression (M. Gao et 
al., 2014). Another type of bone marrow-derived cells, megakaryocytes, is 
responsible for platelet production. Recently a group of scientists confirmed 
that the ATP-binding cassette transporter B6 was highly expressed in 
megakaryocyte progenitors (Murphy et al., 2014). Deletion of the ATP-binding 
cassette transporter B6 resulted in the expansion of megakaryocyte 
progenitors, increased platelet counts and platelet activity. Abcb6−/− bone 
marrow–transplanted mice expressed higher levels of C-C motif ligand 5 and 
accelerated atherosclerosis, leading to increased macrophage accumulation 
in atherosclerotic plaques (Murphy et al., 2014). Taken together, 
hematopoietic stem cells exert their effectiveness on atherogenesis via 
differentiation into macrophages/platelets or influencing lipid metabolisms. 
 
1.4.3.3. Direct Reprogramming of Vascular Cells 
Transplantation of endothelial cells is a promising treatment for the repair of 
damaged blood vessels and the growth of new ones after ischemia. However, 
in development of strategies based on the differentiation of pluripotent stem 
cells researchers have found these cells to have limited proliferative potential 
and instable function, presenting a problem when trying to generate enough 
functional endothelial cells for therapy. To address this problem new 
reprogramming protocols have recently been developed (Morita et al., 2015). 
The transcription factor Ets variant 2 (Etv2) is known to be essential for the 
specification of endothelial and hematopoietic lineages in early gestation. 
Etv2 was found capable of directly converting primary human adult skin 
fibroblasts into functional endothelial cells in combination with FOXC2 
through a composite DNA-binding site (Morita et al., 2015). In a more 
complex protocol Etv2 was also shown to be able to directly reprogramme 
human amniotic cells into endothelial cells without an intermediate pluripotent 
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state. In this protocol Etv2 is expressed for two weeks, followed by the 
expression of transcription factors FLI1 and ERG1, while TGF-βis inhibited for 
3 weeks.  Using this method, human mid-gestation lineage-committed 
amniotic fluid–derived cells were converted into a stable, functional and 
proliferative population of vascular endothelial cells. Both of these protocols 
involving Etv2 could be a promising in producing a large pool of endothelial 
cells for treatment (Ginsberg, Schachterle, Shido, & Rafii, 2015). 
Direct reprogramming of adult cells can also be accomplished with the 
application of viral vectors encoding other transcription factors. In one study 
overexpression of eleven candidate genes which are key regulators of 
endothelial development was achieved by lentiviral infection of adult skin 
fibroblasts from a Tie-GFP mouse, leading to an efficient reprogramming of 
skin fibroblasts into endothelial cells (Han et al., 2014). The function of 
derived endothelial cells was confirmed both in vitro and in vivo (Han et al., 
2014). Sayed et al have recently pointed out that viral vectors are more than 
just passive vehicles for transcription factors due to their participation in the 
process of nuclear reprogramming to pluripotency. They manage to 
transdifferentiate human fibroblasts into endothelial cells by the application of 
viral vector carrying the ubiquitin promoter driving firefly luciferase (Fluc). 
These induced endothelial cells were also verified by a series of functional 
assays both in vivo and in vitro (Sayed et al., 2015).  
 
1.4.3.4. Vascular Progenitor Cells 
The presence of vascular resident stem cells has been determined in all three 
layers of the blood vessel wall, the intima, media and adventitia (L. Zhang & Q. 
Xu, 2014) (Figure 1.9). Investigation on murine vessels revealed that Sca-1+ 
progenitor cells exist in the adventitia of large and medium sized vessels, and 
are able to migrate into the intima when seeded on the adventitial surface in 
Matrigel (Y. Hu et al., 2004). This Sca-1+ progenitor cells derived from 
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adventitia of aortic artery are prone to differentiate into smooth muscle cells in 
vitro. Besides adventitia, sca-1+/Lin-/c-kit-/CD34- cells were found in the media 
of mouse thoracic/abdominal aorta and were shown to differentiate into 
endothelial cells or smooth muscle cells in response to VEGF or PDGF in 
culture medium (Sainz et al., 2006). In addition, the intima was also proven to 
have endothelial progenitor cells which could contribute to vascular 
regeneration (Covas et al., 2005; Ingram et al., 2005). The ratio between 
endothelial and smooth muscle cells remains stable under normal 
physiological conditions but is altered markedly in the pathogenesis of 
vascular diseases. Accumulating evidence demonstrates that vascular 
stem/progenitor cells may contribute to this process and lead to vascular 
regeneration (Evelyn Torsney & Qingbo Xu, 2011). Furthermore, it was 
reported there are resident macrophage progenitor cells in the adventitia of 
the mouse aorta. These Sca-1+/CD45+ progenitor cells were not derived from 
circulation and were found at higher levels in a mouse model of 
atherosclerosis, which provides further evidence that vascular resident 
progenitor cells are a heterogeneous population (Peter J Psaltis et al., 2014). 
More information about the vascular progenitor cells is listed in table 1.1. 
Vascular resident stem/progenitor cells have a high potential in 
cardiovascular regeneration therapies (E. Torsney & Q. Xu, 2011). In a recent 
study, adventitial progenitor cells were harvested from veins during coronary 
artery bypass graft (Iacobazzi et al., 2014). These progenitors showed 
antioxidant properties with up-regulation of antioxidant enzymes such as 
superoxide dismutase and catalase, the effects of which can be abolished by 
pharmacological inhibition of superoxide dismutase. In a mouse limb 
ischemia model, injection of these progenitor cells induced 
neovascularization which offered protection from ischemia (Iacobazzi et al., 
2014). The role of human saphenous vein-derived adventitial progenitor cells 
was investigated in a similar mouse model of limb ischemia. Transplanted 
cells reached their therapeutic target and triggered revascularization of 
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ischemic limbs. In addition, FLT-1 gene silencing in these progenitor cells 
markedly reduced their ability to form tubes, confirming the outcomes from 
predicted expressional studies (Gubernator et al., 2015). The differentiation of 
vascular progenitor cells plays crucial roles in vascular diseases (Figure 1.10). 
Therefore, medications which are involved in cell differentiation were heavily 
investigated. Resveratrol is a natural phytochemical which was recently found 
to induce vascular stem/progenitor differentiation into endothelial cells, which 
express CD31 and eNOS with the great reduction of miR-21, Akt 
phosphorylation and nuclear β-catenin expression. Progenitor cells applied 
with resveratrol treatment demonstrated an enhanced ability for 
re-endothelialization ex vivo and reduced lesion formation was seen with a 
resveratrol diet in a mouse model of vessel graft (Campagnolo et al., 2015).  
Vascular disorder in the lung could be a lethal disease at the final stage, 
and is related to the loss of functional microvasculature (Frid et al., 2006). 
Progenitor cells had been found in lungs adjacent to small vessels (Nadaud et 
al., 2015). These cells can differentiate into smooth muscle cells in vitro. In 
vivo an increased recruitment of these progenitors in response to chronic 
hypoxia was observed. Subsequently, these progenitors can differentiate into 
smooth muscle cells in the remodeled vessels, suggesting the participation of 
the progenitor cells in vascular remodeling (Nadaud et al., 2015). 
Furthermore, resident endothelial cells and progenitors were capable of 
proliferation and restoring endothelial barrier function after inflammatory lung 
injury (Mao, Ye, Liu, Song, & Liu, 2015). The suppression of endothelial and 
progenitor cell proliferation by blocking intrinsic nuclear factor-κB at the 
barrier repair phase was associated with an augmented endothelial 
permeability and impeded endothelial barrier recovery (Mao et al., 2015). In 
lungs, 8 weeks after injury, both endothelial and progenitor cells contribute to 
endothelial repair for endothelial barrier restoration.  
Sca-1+ markers did not express in human beings. Thus more markers 
representing vascular progenitor cells were involved. Gli1+ perivascular cells 
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expressed typical MSC markers, exhibit trilineage differentiation in vitro and 
substantially contribute to organ fibrosis in vivo (Kramann et al., 2015). 
Experiments in large animal models are of great value where possible. One 
group managed to isolate a population of 
CD44+CD56+CD90+CD105+CD34-CD45- progenitor cells from the porcine 
aorta, which was shown to be useful for vascular regeneration in the pig 
model (Zaniboni et al., 2014). Taken together, the current findings 
demonstrate a great potential to use resident stem cells for vascular 
regeneration and angiogenesis. The mechanism of stem/progenitor cell 
differentiation into endothelial or smooth muscle cells may involve in the 
alteration of biomechanical stimuli, i.e. shear stress and cyclic strain (C. 
Zhang, Zeng, Emanueli, & Xu, 2013). Accumulating evidence indicates that 
laminar shear stress and cyclic strain could induce the differentiation of 




Figure 1.9. Adventitial progenitor cells. Various vascular wall progenitor 
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cells were discovered within the mural layer of veins or arteries, for instance, 
Sca-1+ smooth muscle progenitors, Sca-1+ CD45+ macrophage progenitors in 
mice, CD34+CD31- mesenchymal stem cell and CD44+ multipotent stem cells 
in humans (Peter J Psaltis & Robert D Simari, 2015). 
 
 
Figure 1.10. Vascular resident stem/progenitor cells were discovered in 
all 3 layers of vessels. In injured blood vessels, vascular stem/progenitor 
cells are capable of migrating into the damaged area in response to various 
stimuli. The cells can then differentiate either into endothelial or smooth 
muscle cells, respectively, depending on the profile of different cytokines 
released. The migration and differentiation of vascular stem/progenitor cells 
contributes to angiogenesis, endothelial repair, and neointimal formation (Xie, 




Table 1.1 Summary of published adventitial progenitor cells (Yanhua Hu 
& Xu, 2011) 
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apoE-/- mice Adventitia SMC Sca-1 
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1.5. Treatment of Atherosclerosis 
A healthy lifestyle is always the best treatment for atherosclerosis. Besides, 
recommended treatment of atherosclerosis includes but not limited to a 
plethora of drugs, coronary artery bypass grafting and percutaneous 
transluminal coronary angioplasty (PCI).  
Various medications were invented to retard or even reverse the process of 
atherosclerosis. Cholesterol medications, or known as statins and fibrates, 
are able to substantially lower the concentration of low-density lipoprotein 
(LDL) cholesterol, preventing the arteries from the buildup of fatty deposits. 
Meanwhile, the upregulation of high-density lipoprotein (HDL) cholesterol by 
the application of cholesterol medications may also help mitigate 
atherosclerosis. Anti-platelet medications such as aspirin could be prescribed 
to reduce the chance of forming a blood clot and blockage. 
Angiotensin-converting enzyme (ACE) inhibitors slow down the 
atherosclerosis by reducing the blood pressure as well as establishing other 
beneficial effects on vascular system. Beta blocker medications are capable 
of reducing heart rate and blood pressure which decrease the demand of 
patient’s heart and relieve the symptoms of chest pain. Other medications 
include but not limited to calcium channel blockers, water pills and specific 
medications for certain complications of atherosclerosis.  
Surgical procedures are required once patients have severe symptoms of 
atherosclerosis. For angioplasty and stent placement, a long, thin catheter is 
inserted into the narrowed part of patient’s artery. A second catheter 
containing a deflated balloon is subsequently delivered into the narrowed 
area of the artery. The balloon is then inflated. The stent is subsequently 
expanded, compressing the deposit against the vessel wall and widening the 
narrowed artery. The stent is made of mesh metal which is usually coated 
with different drugs to prevent the arteries from re-stenosis. After the surgery, 
the stent is normally left in the narrowed artery to keep it open (Figure 1.11). 
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Coronary artery bypass grafting (CABG) is to create a bypass using a vessel 
from great saphenous vein or internal mammary artery, which allows blood to 
flow around the blocked or narrowed arteries. Other surgical treatments 
include endarterectomy and fibrinolytic therapy (Janet M Torpy, Lynm, & 
Glass, 2004).  
 
 
Figure 1.11. Schematic representation of percutaneous coronary 
intervention (PCI) (J. M. Torpy, Lynm, & Glass, 2008). Catheter with 
balloon and stent is delivered into narrowed area of coronary artery. Balloon 
is then inflated and retreated. Stent is left and kept open to support the lumen.  
 
1.5.1. Complications of PCI 
Percutaneous coronary angioplasty, as a non-surgical treatment of 
atherosclerosis, is less invasive compared to the coronary artery bypass 
grafting (CABG). However, long-term restenosis (Figure 1.12) after PCI 
surgery brings new challenge for the treatment of atherosclerosis (Nikol, 
Huehns, & Höfling, 1996). 
Restenosis is the recurrence of stenosis. When narrowed blood vessels 
received treatment such as PCI to clear the blockage and widen the narrowed 
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artery, restenosis can occur after the surgery, leading to restricted blood flow. 
Once a stent is applied and restenosis happens, the situation is named 
in-stent restenosis. If restenosis only occurs after balloon angioplasty, it is 
named post-angioplasty restenosis (Hamid & Coltart, 2007). Restenosis after 
PCI is characterized as a distinct pathophysiological process other than 
atherosclerosis (Costa & Simon, 2005). Inflammation as well as the 
proliferation of fibroblast and smooth muscle cells plays important roles in 
restenosis. In human studies, a mural thrombus could be formed at the early 
stage of atherosclerosis, prior to the invasion of smooth muscle cells, 
T-lymphocytes cells and macrophages. The implanted stent can be fully 
covered by this early neointima 4 weeks after the surgery. Extracellular matrix 
subsequently enhances and smooth muscle cells can be discovered with 
lymphocytes next to the stent (Toutouzas, Colombo, & Stefanadis, 2004). 
Late phase of post-angioplasty restenosis involves in the dedifferentiation, 
proliferation and migration of smooth muscle cells towards intima. These 
smooth muscle cells are capable of releasing hyaluronan, proteoglycans and 
collagens, all of which compose the majority of neointimal hyperplasia 
(Toutouzas et al., 2004). Due to the high risk of post-angioplasty restenosis in 
patients who received PCI, drug-eluting stents (DES) was hence invented. 
DES is coated with medications which could prevent the surgical arteries from 
restenosis. For instance, sirolimus, as an inhibitor of mTOR, can substantially 
suppress the migration and proliferation of smooth muscle cells, decreasing 
the extent of restenosis in the arteries with stents (Curcio, Torella, & Indolfi, 
2011). Although DES showed a significant improvement in restenosis 
compared to bare metal stents, there is no marked difference in late stent 
thrombosis incidence. 
Stent thrombosis is defined as a newly formed thrombus in the segment 
where a previous stent was implanted. The reasons for the occurrence of late 
stent thrombosis are variable. Stenting across ostia of major arterial branches, 
exposure to radiation therapy, plaque disruption in non-stented arterials, 
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extensive plaque prolapse and diffuse in-stent restenosis can all contribute to 
late stent thrombosis, impairing intimal healing over the stent struts (Farb, 
Burke, Kolodgie, & Virmani, 2003). 
 
 
Figure 1.12. Schematic diagram of the postulated pathological 
mechanism of the development of late stent thrombosis with impaired 












1.6. Animal Model of the Vascular Disease 
The first vascular research with animal models dates back to 100 years ago, 
which was a rabbit model published by Ignatowski in 1908 (Getz & Reardon, 
2012). Knowledge of the pathogenesis and therapy of atherosclerotic disease 
and the use of animal models in arteriosclerosis research have evolved 
almost simultaneously. The use of animal models in the study of 
arteriosclerosis is essential in a set of aspects. For instance, evaluation of a 
risk factor as a single independent variable, with almost complete exclusion of 
other factors, can best be performed in animals free of intercurrent diseases 
or abnormalities and with well-known genetic characteristics (Weiss, Kools, & 
Taylor, 2001). On the other hand, the role of vascular injury due to 
angioplasty, alloimmune responses or vein grafts can be investigated alone 
or in combination with other factors that either aggravate or have beneficial 
effects(Xu, 2004). Furthermore, experiments using animals are the only way 
to develop and test new diagnostic, preventive and therapeutic procedures for 
both ethical and practical reasons. The investigator can choose the species, 
time and method, and obtain samples of both tissue and serum as well, as 
these methods would be difficult, if not impossible, in studies with human 
subjects. 
Rabbit is the first and one of the most frequently used animal at all points of 
arteriosclerosis research. Lesions analogous to those in humans have been 
induced in the rabbit by a variety of methods. Since rabbits are very 
susceptible to a cholesterol-enriched diet, hypercholesterolemia and 
atherosclerotic lesions in the intima of large arteries can be obtained shortly 
after administration of the food. The Watanabe heritable hyperlipidemic 
(WHHL) rabbit, which is an excellent model of homozygous familial 
hypercholesterolemia in humans, has also been used.  
Due to well-defined genetic systems of transgenic and knockout mice, a 
number of investigators have used the mouse as an experimental system for 
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arteriosclerosis research (Weiss et al., 2001). Hundreds of inbred lines have 
been established, and the genetic map is relatively well defined, and both 
congenic strains and recombinant strains are available to serve better the 
genetic experimentation. In just a few years, murine lipoproteins have been 
characterized, genetic variants of apolipoproteins identified, and genetic 
variation in susceptibility to atherosclerosis among inbred mouse strains 
demonstrated (Carmeliet et al., 1997; Ivan et al., 2002; Roque et al., 2000). In 
addition, reduced experimental animal numbers can be achieved due to 
inbred strains having low variability, which is also of economic benefit. The 
mouse is becoming a widely used model for studying all aspects of 
arteriosclerosis, and thus, this chapter will discuss all types of mouse models 
for vascular disease, highlight the usage of rat, rabbit and pig models and 
attempt to update progress in the use of animal models for studies on 
vascular diseases. 
 
1.6.1. Mouse Model of Atherosclerosis 
Atherosclerosis is a chronic cardiovascular disease which can remain 
asymptomatic for decades. It is also the leading cause of stroke, myocardial 
infarctions and other vascular diseases, of which mechanism is still not fully 
understood. Animal models are designed to be preliminary tools for a better 
understanding of the pathogenesis, improvement in diagnosis, prevention, 
and therapy of vascular diseases in humans. Animal models are easily 
manageable, as compounding effects of dietary and environmental factors 
can be controlled experimentally. Blood vessel samples can be taken for 
detailed experimental and biomolecular examination. A thorough 
understanding of the animal models is necessary and complete analysis must 
be validated so that the data can be extrapolated to humans. Attracted by the 
well-defined genetic systems, a number of investigators have begun to use 
the mouse as an experimental system for arteriosclerosis research. The 
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specific advantages and disadvantages of using a mouse model are listed 
below (Table 1.2). Since the vascular disorder is a complicated disease, 
which includes spontaneous (native) atherosclerosis, transplant 
arteriosclerosis, vein graft atherosclerosis and angioplasty-induced 
restenosis, several models for studying all types of vascular disease have 
recently been established. Using these animal models, much knowledge 
concerning the pathogenesis of the illness and therapeutic intervention has 
been gained. 
 
Table 1.2. Advantages and disadvantages of mouse models 
 
 
1.6.2. Diet-Induced Atherosclerosis 
In the 1960s, Wissler used a high-fat diet to induce atherosclerosis but the 
diet was toxic to mice (Vesselinovitch & Wissler, 1968). Then Paigen modified 
the formula, however, it still had disadvantages (Paigen, Morrow, Brandon, 
Mitchell, & Holmes, 1985). Even after modification, diet-induced 
atherosclerosis in mice was not as obvious as that in larger animals. The 
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mouse is naturally resistant to atherosclerosis and the lesions in mice are 
very small and limited to the early fatty-streak stage. In 1992, great progress 
was made by genetic manipulation. With the help of genetic techniques, 
apoE-/-, LDL receptor-deficiency (Ldlr-/-) mice as well as other genetic mouse 
models were created to induce more human-like atherosclerotic lesions 
(Piedrahita, Zhang, Hagaman, Oliver, & Maeda, 1992). Numerous animal 
models based on transgenic mice were then invented to mimic various kinds 
of pathological states in human.  
Mice and human have different lipid profiles, limiting the use of mouse 
models in medical research. The primary circulating cholesterol in mouse is 
high-density lipoprotein, and it does not have cholesterol-ester transfer 
protein. Also, the mouse hardly absorbs dietary cholesterol. This is the reason 
that wild type mice are usually resistant to atherosclerosis. Therefore, 
scientists have used genetic engineering to overcome this limitation. Now, 
both apoE-/- and Ldlr-/- mice are widely used in the investigation of a variety of 
vascular diseases (Getz & Reardon, 2012). These mice will not show visible 
vascular lesions when fed a chow diet (Figure 1.13) but may present lesions 
following an atherogenic diet. Meanwhile, other genetic-deficient mice, such 
as hepatic lipase-deficiency and human apoB100 expression models, have 
also been generated to be used in the atherosclerotic field. 
At present, experimental mice are fed in a lower fat diet, and many other 
kinds of ingredients emerge according to the researchers’ requirements. 
However, the atherosclerosis induced by this method is not stable and 
reproductive enough. Wild-type mice have naturally a very low concentration 
of triglycerides and LDL in the serum, but have a very high HDL concentration, 
which would contribute to reducing atherosclerosis. For instance, feeding 
Western-type diet which contains 35% fat, 50% carbohydrate, 15% protein 
cholesterol (0.5 to 1%) and cholic acid (0.1% to 0.5%), mice leads to increase 
in LDL and triglyceride levels but animals display mild atherosclerosis. The 
cholic acid in Western-type diet can prevent cholesterol from converting into 
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bile acid. In addition, the presence of cholic acid helps absorb the fat and 
cholesterol which increases the level of cholesterol in the circulation (Ando et 
al., 2005). It is worth noticing that cholic acid also has an effect on 
inflammation and lipoprotein metabolism, which are the key factors of 
atherosclerosis. However, in mice heterozygous or homozygous for a 
disrupted apoE gene and LDL receptor gene, a dramatically increase of 
atherosclerosis was discovered after feeding an atherogenic diet (S. H. 
Zhang, Reddick, Burkey, & Maeda, 1994). 
 
 
Figure 1.13. Atherosclerosis in the aorta. The image representation of 
aortic root lesions of atherosclerosis from apoE (a) and LDL (b) deficient mice 
at the age of 36 months with normal chow diet (Piedrahita et al., 1992). 
 
1.6.3. Mouse Model of Vascular Injury 
Spontaneous development of atherosclerosis in experimental animals is 
time-consuming. Moreover, unlike human whose atherosclerosis mainly 
happens in coronary arteries, carotid, and peripheral vessels, murine 
atherosclerosis occur more frequently in aortic arch, aortic root and 
innominate artery (Getz & Reardon, 2012). By applying local interventions, 
researchers are able to not only reduce the experimental time but also to 
select an optimal location and control the extent of the injury. Balloon injury, 
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guide wire injury, blood flow cessation and stenosis collar were hence 
developed (Xu, 2004).  
Periarterial cuff placement was developed several years ago (Karper et al., 
2011). This method allows the structural integrity of the endothelium to be 
maintained. Typically, under anesthesia, the target artery will be separated 
from surrounding tissue. A tiny polyethylene cuff will loosely sheath the artery 
and be tied with a suture. Since the cuff is larger than the vessel, it would not 
affect blood flow. Then the target artery will be replaced and the wounds will 
be sutured.  Electric injury to the carotid artery of mice can induce vessel 
injury, in which the artery should be well isolated firstly. A bipolar 
micro-coagulator can be applied, positioned perpendicularly to the 
longitudinal axis of the artery to do the injury. A very small current pulse can 
cause the injury and reducible neointima formation. The blood flow cessation 
model can be the easiest way to induce vascular injury. Remodeling is carried 
out with ligation of the target artery, i.e. common carotid artery near its 
bifurcation. Then the wound is sutured and the mouse is allowed to recover. 
 
1.6.4. Stent Implantation 
Stent implantation in a mouse model, along with administration of drugs and 
chemokines, is a powerful tool to help understand the mechanism and 
solutions of restenosis caused by a stent implantation in human beings. 
Under anesthesia, before the isolation of the common carotid artery, a knot is 
bound around the common carotid artery, 2 knots around the left external 
carotid artery and last knot can be around the internal carotid artery. The 
blood flow is stopped by binding the knots on internal and external carotid 
arteries, and pulling the knot on the common carotid artery. An arteriotomy will 
be made at the external carotid then a silicon tube containing stent is inserted 
into common carotid artery to the target position. Later on, pull back the tube 
by using guide wire and bind the knot on external carotid artery tightly remove 
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another two knots and close the wound of skin (Simsekyilmaz et al., 2013).  
Compared to the mouse model of guide-wire injury, stent implantation 
mainly focuses on the mechanism of In-stent thrombosis after percutaneous 
transluminal (coronary) angioplasty (PTCA) with stent implantation in human 
beings. The development of a miniaturized stent for mouse carotid artery, 
combined with different knock-out mice allows the study of particular 
molecular mechanisms for in-stent thrombosis and the tests of various 
stent-coating drugs. However, the mouse model of guide-wire injury may be 
more relevant to clinical intra-arterial manipulation but cannot represent the 
in-stent neointimal formation.   
 
1.6.5. Guide-Wire Injury 
Guide-wire injury to the vessel can be achieved by 3 passages of a 0.25mm 
diameter angioplasty guide wire (Figure 1.14). Under anesthesia, the femoral 
artery can be separated clearly with the help of a surgical microscope. A 
suture is inserted through the femoral artery in advance in preparation for 
further ligation. Then, an arteriotomy can be made, and the guide wire is 
inserted forward until the aortic bifurcation. The guide wire is then moving 
back and forth three times to ensure a complete endothelium denudation. 
After removing the guide wire, the arteriotomy site should be ligated 
immediately and the wound is sutured (Roque et al., 2000). Firstly applied by 
Roque et al. in 2000, guide-wire injury model soon became widely accepted 
as it closely resembled the injury of the endothelium and vessel wall. Typical 
neointimal hyperplasia undergoes three lesion processes. The first one is a 
marked loss of smooth muscle cells at an early stage, probably caused by 
biomechanical stress (Mayr et al., 2000). Next comes to the massive 
infiltration of mononuclear cells (CD11b/18+). Increasing adhesion and 
chemokines secretion from smooth muscle cells and endothelial cells caused 
by biomechanical stress and dead cells from early stage may explain the 
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continuous recruitment of inflammatory cells. At the final stage, cell 
differentiation, migration and accumulation are involved. Vascular smooth 
muscle cells mainly constitute the neointimal hyperplasia (Zou et al., 1998). 
A major and common complication in vessel injury models is the 
development of neointimal lesions as early as the 1st week with the peak in 
3-4 weeks. Using these models, smooth muscle cell migration and 
proliferation can be studied. Neointimal lesions usually stop growing in 
denuding injury models as soon as the luminal surface gets re-endothelialized.  
Restricting the morphometric analysis to denuded segments assures that all 
measurements are performed on segments of vessels that have not been 
influenced by the variable of endothelial regeneration.  Unfortunately, not 
many investigators rigorously control endothelial regeneration and 
clot-dependent effects on neointima formation.  Like the rat balloon injury 
model, the proliferation of SMC starts in the media within a few days after 
denudation and if no re-endothelialization occurs, proliferating SMC can be 
found in the neointima typically within a week. If re-endothelialization 
occurred before SMC could migrate into the intima medial hypertrophy and 
hyperplasia will be observed since medial SMC proliferation precedes the 





Figure 1.14. Guide-wire injury mouse model. Representative figures of 
cross sections of guide-wire injury mouse model in wild-type and CD40-/- mice 
(left panel). Schematic figure of guide-wire injury and angiotomy of femoral 

















1.7. Adipose Tissue 
Adipose tissue is a loose connective tissue which mostly contains adipocytes, 
as well as a smaller stromal vascular fraction (SVF). SVF consist of 
adipose-derived stem cells (ADSC), fibroblasts, vascular endothelial cells and 
immune cells. Adipose tissue was initially thought to be only an inert energy 
storage organ. However, accumulating studies indicated that adipose tissue is 
actually the largest endocrine organ, releasing an array of signaling 
molecules, named adipokines. (Kershaw & Flier, 2004) Adipose tissue is 
typically classified into two sub-families: brown adipose tissue and white 
adipose tissue. The latter is capable of secreting adipokines and has an effect 
on other organs both systematically and locally, which may contribute to 
various cardiovascular diseases (Kwon & Pessin, 2013). 
 
1.7.1. Perivascular Adipose Tissue (PVAT) 
Blood vessels are composed of three different layers: intima, media and 
adventitia. The perivascular adipose tissue harbors on the adventitia side of 
almost every blood vessel except for cerebral vasculature (Y.-J. Gao, 2007). 
Since there is no anatomical barrier between perivascular adipose tissue and 
the vessel wall, perivascular adipose tissue is regarded as an endocrine 
organ and has a direct effect on the vasculature (Rajsheker et al., 2010) 
(Figure 1.15). In 2005, PVAT was proved to release adipokines which had an 
impact on the proliferation of vascular smooth muscle cells (Barandier, 
Montani, & Yang, 2005). In 2009, Takaoka demonstrated that implanting 
abdominal adipose tissue around the blood vessel can increase the 
neointimal formation after endovascular injury (Takaoka et al., 2009). Taken 
together, adipose tissue as well as its secretion could have a great impact on 
vascular remodeling. 
There are two types of adipose tissues in human bodies: brown adipose 
tissue and white adipose tissue. Brown adipose tissue is mainly responsible 
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for generating heat which is often regarded as good fat, containing much 
more iron-containing mitochondria and tiny blood vessels than white adipose 
tissue does (Cinti, 2011). PVAT is a mixture of brown adipose tissue and white 
adipose tissue. The composition of PVAT varies from region to region. For 
instance, PVAT surrounding thoracic aorta is mainly composed of brown 
adipose tissue, while PVAT around abdominal aorta and mesenteric artery is 
mainly white adipose tissue, indicating their diverse functions in different 
regions (Frontini & Cinti, 2010; P. Wang et al., 2008). 
Perivascular adipose tissue is not only a loose connective tissue, but also 
an endocrine organ. It was well known that adipocytes can induce the 
proliferation of smooth muscle cells, but the mechanism was not clear until 
2005. Barandier et al. discovered that growth factors present in conditioned 
medium from mature adipocytes or preadipocytes can induce the proliferation 
of vascular smooth muscle cells, the effect of which could be diminished by 
proteinase K (Barandier et al., 2005). Later, Lamers et al. demonstrated that 
conditioned medium from adipocytes promoted the migration of vascular 
smooth muscle cells (Lamers et al., 2012). Numerous studies focused on the 
relationship between the characteristics of PVAT and obesity. One research 
revealed that PVAT from obese or aged mouse could significantly enhance 
the proliferation of vascular smooth muscle cells, indicating that PVAT’s 
features may vary according to donors’ body weight and age. This difference 
may be caused by the different composition of adipokines released by the 
donors’ PVAT which subsequently influenced the vasculature locally or 





Figure 1.15. Interaction between perivascular adipose tissue and 
vessels (Meijer et al., 2011). Perivascular adipose tissue could secret 
various adipokines such as adiponectin and leptin, which could directly 
participate in vascular remodelling with endothelium, smooth muscle cells, 
monocytes, lymphocytes and other mediators involved. ADRF: 
adventitia-derived relaxing factor; Ang II: angiotensin II; IL8: interleukin 8; 












1.8. Chemokine and Adipokine 
Chemokines belong to a family of tiny cytokines which are secreted by cells, 
inducing chemotaxis of nearby cells. They have a relatively low molecular 
weight between 8 to 12 kDa, some of which are able to stimulate the 
recruitment of leukocytes (Mélik-Parsadaniantz & Rostène, 2008). All the 
chemokines share a similar genomic, consisting of three exons and two 
introns (Groves & Jiang, 1995). Chemokines have been classified into four 
subfamilies according to the spacing of their first two cysteine residues: CXC, 
CC, CX3C and XC (Mélik-Parsadaniantz & Rostène, 2008). Chemokine 
receptors belong to a seven transmembrane G-protein coupled receptor 
family with a short, acidic N-terminal end, three intracellular, three 
extracellular hydrophilic loops, and an intracellular C-terminus (Murdoch & 
Finn, 2000). Chemokine receptors transduce cell signaling after ligand 
binding, promoting various signaling pathways to generate the migratory 
effect.  
Adipokines belong to a family of chemokines which are exclusively 
secreted by adipose tissue. They share the same characteristics as other 
chemokines. Leptin was the first adipokine discovered in 1994, opening a 
new perspective in many fields including the cardiovascular research. Later, 
other adipokines, such as adiponectin, visfatin and resistin were successively 
identified. Adipokines are mainly released by white adipose tissue, and can 
induce various physiological or pathological activities. For instance, in obese 
individuals, plasma leptin is higher than that in the healthy individuals. A 
higher concentration of leptin was believed to promote inflammatory process 
whereas adiponectin was regarded as a protective role in inflammation  
(Kwon & Pessin, 2013). 
 
1.8.1. Leptin and Its Role in Vascular Remodeling. 
Leptin is a 16 kDa peptide hormone responsible for long-term regulation of 
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energy balance. Firstly discovered in the hypothalamus in 1994, leptin 
opened a new gate to study the role of adipose-derived chemokines or so 
called adipokines (Y. Zhang et al., 1994). Elevated leptin concentration in 
circulation strongly correlates with obesity (or body mass index), 
hyperinsulinemia and insulin resistance. Body weight loss could decrease the 
concentration of serum leptin but how body absorbs or expels serum Leptin 
mechanically was still unknown. Leptin was previously known to play roles in 
the regulation of food intake and energy expenditure, but increasing studies 
have demonstrated its additional effects on the cardiovascular system (Figure 
1.16), where widespread distribution of leptin receptor (OBR) has been 
identified  (Sweeney, 2002). Leptin may contribute to atherosclerosis 
through activation of various mechanisms, including endothelial dysfunction 
(Lembo et al., 2000), lipid metabolism (Lundåsen, Liao, Angelin, & Rudling, 
2003; Maingrette & Renier, 2003), proinflammatory effect (Shamsuzzaman et 
al., 2004) and proliferation of smooth muscle cells (Beltowski, 2006; Parhami, 
Tintut, Ballard, Fogelman, & Demer, 2001). Shan J et al discovered that leptin 
stimulated proliferation of murine smooth muscle cells (SMCs) via the 
mTOR-signaling pathway, which may contribute to enhancing neointimal 
hyperplasia in obese humans (Shan et al., 2008). Deletion of either leptin or 
OBR in ob/ob (leptin-deficient) or db/db mice significantly mitigated the 
formation of neointima (Schäfer et al., 2004). The mechanism of 
leptin-induced neointimal formation after guide-wire injury in the femoral 
artery is believed independent of blood pressure and energy balance (Bodary 
et al., 2007). In addition, leptin may participate in vascular remodeling and 
stiffness by altering extracellular matrix production in VSMC through the 
PI3K/Akt pathway (Martínez-Martínez et al., 2014). Taken together, leptin can 







Figure 1.16. The systemic effect of enhanced serum leptin on the 
cardiovascular system (Yang & Barouch, 2007). Obese individuals have 
higher concentrations of leptin, which may contribute to various diseases of 
heart and vasculature via different mechanisms. Selective central leptin 
resistance leads to hypertension, atherosclerosis and LVH. 
 
The pleiotropic characteristics of leptin owe to the ubiquitous distribution of 
leptin receptors (OB-R). Leptin receptor belongs to a family of 
transmembrane receptor which has a similar structure to class 1 cytokine 
receptor family, such as LIF, IL-2, and IL3 etc (Hegyi, Fülöp, Kovács, Tóth, & 
Falus, 2004). OB-R has six spliced forms: OB-Ra, OB-Rb, OB-Rc, OB-Rd, 
OB-Re and OB-Rf (Lee et al., 1996). Six spliced forms are classified into 
three groups: short (OB-Ra, OB-Rc, OB-Rd, OB-Rf), long (OB-Rb), secreted 
(OB-Re). Short isoforms is also capable of transducing signaling pathways 
via JAK but their activities are substantially much weaker than those induced 
by long isoforms (Bjørbæk, Uotani, da Silva, & Flier, 1997). Li et al addressed 
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the role of OBRa by deleting the OBRa-specific exon in mouse model. These 
mice displayed the phenotype with decreased fasting blood glucose and an 
improved glucose tolerance. OBRa overall showed a similar role compared to 
OBRb but with a limited control of leptin metabolic effects. The expression of 
OBRc is either as abundant as or more prevalent than OBRa in various 
tissues, such as cortex, hippocampus and lung, indicating that OBRc may be 
at least as important as OBRa in these tissues in mediating the effect of leptin. 
Interestingly, when the expression of OBRb is discovered, engagement of 
OBRb into heteromers with short isoforms of leptin receptors is likely to occur, 
implying the interactions of OBRb versus the short isoforms (Dam & Jockers, 
2013). OBRe, as a soluble leptin receptor in blood, has been reported 
secreted by adipose tissue alone or in combination with leptin. Serum leptin 
and OBRe has an inverse proportion during the diurnal variation. In 
leptin-deficient humans, OBRe could bind to leptin in the serum, exhibiting the 
biological activity of leptin (Gavrila et al., 2003). Therefore, only OB-Rb is 






Figure 1.17. The structure of leptin receptor b in resting, activation and 
in-activation stages (Coppari & Bjørbæk, 2012). a, the resting stage of the 
long isoform of the leptin receptor b which exists as a homodimer at the 
plasma memberane. b, when leptin binds to leptin receptor, the two receptor 
subunits undergo the changes of conformation, leading to the 
transphosphorylation and transactivation of JAK2 and SFK protein. 
Subsequently, activated JAK and SFK phosphorylate Tyr residues of leptin 
receptor b. c, leptin receptor b is inactivated by protein tyrosine phosphatase 
1B (PTP1B), followed by the inhibition of JAK2 via SOCS3.  
 
1.8.2. Adiponectin 
Adiponectin is a 244-amino-acid-long polypeptide exclusively released by 
adipose tissues. Identified by different methods from four groups, adiponectin 
was also named GBP-28, apM1, AdipoQ and Acrp30 (Maeda et al., 1996). 
The concentrations of plasma adiponectin and body weight of individuals 
have an inverse relationship. Massive evidence suggested that adiponectin is 
a beneficial adipokine with anti-diabetic, anti-inflammatory and 
anti-atherogenic effect (Matsuzawa, 2010). 
Adiponectin mainly binds to three receptors: adiponectin receptor 1 
(ADIPOR 1), adiponectin receptor 2 (ADIPOR 2) and T-cadherin. ADIPOR1 
and 2 are G protein-coupled receptors (GPCRs), possessing 
seven transmembrane domains. Activation of these two receptors mediates 
increased AMPK and PPAR-α ligand activity. One group revealed that 
adiponectin had anti-atherogenic and anti-inflammatory properties during the 
development of atherosclerosis (Arita et al., 2002). For instance, the 
expression of adiponectin was greatly increased in sub-intimal area after the 
vascular endothelium injury (Okamoto et al., 2000). Elevating concentration of 
adiponectin significantly reduced the adhesion of monocyte and reduced the 
expression of E-selectin, VCAM-1 and ICAM-1 on the endothelium (Ouchi et 
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al., 1999), both suggesting that adiponectin had a protective role against 






























1.9. Leptin-Induced Signaling Pathways 
1.9.1. Leptin Receptor B (OBR) 
As mentioned previously, the leptin receptor codes for six leptin receptor 
isoforms via RNA splicing. All of them have an extracellular domain which can 
bind to leptin but only leptin receptor b contains a full-length intracellular 
domain, which is necessary for signal transduction cascade (Friedman & 
Halaas, 1998). The action of OBR is commonly induced by JAK/STAT 
(Zabeau et al., 2003), AMPK (Minokoshi et al., 2002), PI3-Akt and MAPK 
(Frühbeck, 2006) pathways, which can be inhibited by cytokine signaling 3 
receptors (SOCS3) (Frühbeck, 2006) (Figure 1.18). 
 
1.9.2. JAK/STAT Signaling Pathway 
The JAK-STAT pathway transmits the signal from outside the cell into gene 
promoters inside the nucleus, which is the main signaling alternative to 
second messenger system. Leptin receptor b structurally binds to Janus 
kinase family of tyrosine kinases (JAK2). Once stimulated by leptin, leptin 
receptor b starts dimerization, leading to its activation and 
auto-phosphorylation of JAK2. In the meantime, JAK2 also phosphorylates 
leptin receptor b thus activating various downstream signaling pathways 
(Banks, Davis, Bates, & Myers, 2000). Leptin receptor b contains four tyrosine 
residues (Tyr974, Tyr985, Tyr1077 and Tyr1138) and the latter three are closely 
related to JAK phosphorylation. Replacement of either one of the three 
residues or combinations of them caused leptin resistance and obesity, 
suggesting that all three intracellular tyrosine residues are required for 
downstream activation (Hekerman et al., 2005). 
For STAT3 pathways, leptin mainly stimulates STAT3 but can activate 
STAT1, -5, -6 as well. Tyr1138 is required for activation of STAT1 and STAT3 
(Münzberg, Björnholm, Bates, & Myers Jr, 2005). Replacing Tyr1138 residue 
with a serine residue leads to inactivation of STAT3 without affecting the 
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activation of other STAT family members. In response to leptin, STAT3 binds 
to phospho-Tyr1138, allowing JAK2 to phosphorylate and activate STAT3 
(Morris & Rui, 2009). SOCS protein was thought to be the negative-feedback 
of JAK/STAT pathway. With a SH2 domain, SOCS can be induced by a wide 
range of cytokines, serving as a negative regulator (Müller, Kuttenkeuler, 
Gesellchen, Zeidler, & Boutros, 2005). The knockdown of SOCS3 by RNA 
interference greatly enhanced the tyrosine phosphorylation of JAK2 and 
STAT3 (Dunn et al., 2005).  
Brief leptin treatment could stimulate phosphorylation of STAT3, which had 
peak activation after 30 to 60 minutes in human embryonic kidney (HEK) 293 
cells, declined to 80% of peak level at 4 hours after the treatment and 
remained at 60% of peak level at 24 hours after the treatment. However, 
phosphorylation JAK2 was more transient and dropped quickly to 40% to 50% 
of peak level at 1 to 4 hours after the treatment and below 30% after 8 hours 
in human embryonic kidney (HEK) 293 cells. In addition, SOCS3 was 
undetectable before leptin treatment, but can be detected 8 hours after leptin 
treatment by Western blotting, suggesting SOCS3 was an important feedback 
mechanism for JAK/STAT signaling (Dunn et al., 2005). 
 
1.9.3. MAPK (mitogen-activated protein kinase) Cascade 
The MAPK pathway can be stimulated via either leptin receptor a or b but the 
activation is much stronger when induced by leptin receptor b. Leptin triggers 
MAPK pathway in two different ways: JAK2 receptor-dependent activation 
and independent phosphorylation, both of which need an intact catalytic 
domain of SHP-2 (Bjørbæk et al., 1997). 
Activation of MAPK pathways can be observed both in vivo and in vitro, 
participating in many pathological and physiological processes. For instance, 
the phosphorylated ERKs led to the expression c-Fos and Egr-1 which were 
related to cell proliferation and migration. In osteoplastic precursor cells, it has 
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been concluded that leptin induced cell apoptosis via MAPK cascade through 
ERK 1/2 activation of cytosolic phospholipase A, which inversely contributed 
to cytochrome c release and the induction of caspase3 and caspase 9 (G. S. 
Kim et al., 2003). Besides ERK 1/2, leptin could activate other members of 
MAPK family such as p38 MAPK pathway. In vascular smooth muscle cells, 
leptin reportedly led to hypertrophy via p38 MAPK pathway, indicating a 
potential relationship between leptin and vascular remodeling (Mayr et al., 
2000).  
 
Figure 1.18. Well-established signaling pathways induced by leptin 
receptor b (Morris & Rui, 2009). Leptin binds to leptin receptor b, activating 
the phosphorylation of LEPRb-associated JAK2 on Tyr985/1077/1138. SHP2 binds 
to Tyr985 which is related to the activation of MAPK pathway. Suppressor of 
cytokine signaling-3 (SOCS3) also binds to Tyr985 to inhibit leptin signaling 
as a negative feedback. STAT 3 and 5 are phosphorylated by the activation of 





Various intracellular signaling pathways have been identified during cell 
migration which includes MAPK cascades, Ser/Thr and Thy kinases, scaffold 
proteins, etc. However, one group of particular families of proteins seems 
most relevant to cell migration, the GTPases. Small GTPases are a family of 
hydrolase enzymes which can catalyze and hydrolyze guanosine 
triphosphate (GTP) to guanosine diphosphate (GDP). The activation of 
GTPases is strongly linked to cell proliferation, differentiation, migration, and 
lipid vesicle trafficking. Among all 20 members of GTPases family, three 
GTPases, Rac, Rho and Cdc42, play crucial roles in coordinating 
cytoskeleton during cell migration (Xin Zhou, Herbst-Robinson, & Zhang, 
2012) (Figure 1.19, cell type not mentioned in the review). Tissue culture 
studies in fibroblast showed that Rho was involved in assembly of myosin 
filaments which was a contractile actin. However, Rac and Cdc42 were mainly 
related to the polymerization of actin to form lamellipodium and filopodia 
respectively (Raftopoulou & Hall, 2004). Additionally, all three GTPases 
facilitate the matrix adhesion complexes as well as affect the microtubule 
cytoskeleton and gene transcription (Etienne-Manneville & Hall, 2002).  
Cell migration is achieved by the extension of lamellipodium in the front, 
followed by the contraction of cell body and the detachment of adhesion site 
at the rear. Rac and Cdc42 are indispensable in the front to regulate actin 
polymerization and lamellipodium. The highest concentration of active Rac in 
the front leading edge can be detected in the migrating fibroblasts (Kraynov et 
al., 2000). The major target of Rac for the stimulation of lamellipodial 
extension is WAVE proteins. On the other hand, Cdc42 mainly binds to WASP 
proteins, activating the Arp2/3 complex to trigger actin polymerization (Welch 
& Mullins, 2002). WAVE/WASP can bind to GAPs and GEFs, hence 
generating positive or negative feedback to regulate the extent of actin 
polymerization (Ridley et al., 2003). Chemotaxis requires extracellular cues 
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which are regulated by Cdc42. For instance, once Cdc42 was inhibited in 
macrophages, the cells displayed a random migration. What is more, if Rac 
activity was blocked, the macrophages did not migrate anymore, indicating 
that Cdc42 directs Rac activity in the cell front (Etienne-Manneville & Hall, 
2002). Unlike Rac and Cdc42 mainly acting in the front, Rho was believed to 
control the contraction and retraction forces at the rear, which was also 
associated with focal adhesion assembly. Also, the distribution of Rho activity 
during the cell migration displayed an inverse pattern to Rac and Cdc42 
(Raftopoulou & Hall, 2004). Activation of Rac in the front edge could suppress 
Rho activity. Meanwhile, the activation of Rho at the sides and rear would 
suppress Rac activity, indicating different roles of Rac, Cdc42, and Rho 
during cell migration. Inhibition of Rho resulted in an extended tail due to the 
decreased ability of actomyosin-based contractility. The underlying 
mechanism of Rho during cell migration was hence developed. Myosin 
filament assembly is considered as a major target of Rho, which is activated 
by Ser/Thr kinase p160ROCK (Alblas, Ulfman, Hordijk, & Koenderman, 2001). 
Phosphorylation of 160ROCK is responsible for the phosphorylation of LIM 
kinase, resulting in the phosphorylation of cofilin and myosin light chain, 
leading to the F-actin stabilization and myosin crosslinking (Raftopoulou & 





Figure 1.19. Representative figure of cell polarity with the activation of 
relevant GTPases families. Cell migration depends on cell polarity with cell 
protrusions such as filopodia and lamellipodia in the front and focal adhesion 
at the rear. GTPases family plays an important role in cell polarity. RhoA is 
mainly involved in cell contraction at the back. Cdc42 is responsible for 
controlling the actin cytoskeleton in filopodia. Rac helps the formation of 
lamellipodia. However, recent studies showed that all three GTPases family 












1.11. Hypothesis and Aims of Study 
Obesity is associated with a significantly higher risk of cardiovascular disease 
(Korner & Aronne, 2003). The expansion of adipose tissue in obese 
individuals is closely linked to the secretion of plasma adipokines, which were 
originally thought only to be related to energy homeostasis (Lehr, Hartwig, & 
Sell, 2012). Among all adipokines, including adiponectin, visfatin, and resistin, 
leptin was firstly discovered in 1994 (Conde et al., 2011). Obese individuals 
strongly correlate with higher levels of plasma leptin, a peptide hormone, 
mainly secreted into the circulation by white adipose tissue (Schulze & 
Kratzsch, 2005). Accumulating articles demonstrated that leptin has various 
biological effects on cell migration, proliferation and differentiation (Beltowski, 
2006; Lembo et al., 2000; Parhami et al., 2001; Schäfer et al., 2004; 
Schroeter et al., 2008).  
Recent studies have shown that a range of multipotent stem/progenitor 
cells exist in the adventitia of the vascular wall (Majesky, Dong, Hoglund, 
Mahoney, & Daum, 2011; E. Torsney & Q. Xu, 2011; Xie et al., 2016). Our 
laboratory identified the presence of adventitial progenitor cells, which are 
positive for Sca-1 and CD34 (Y. Hu et al., 2004). This heterogeneous 
population of cells can give rise to different cell lineages, including SMCs (Y. 
Chen et al., 2013; M. M. Wong et al., 2013), endothelial cells (Wong et al., 
2014; E. Zengin et al., 2006) and macrophages (P. J. Psaltis et al., 2014; P. J. 
Psaltis & R. D. Simari, 2015), which may contribute to neointimal formation 
(Xie et al., 2016). Considering the positive correlation between plasma leptin 
and cardiovascular disease, several laboratories have investigated biological 
effects of leptin in the cardiovascular system. However, little is known about 
whether leptin exerts an effect on adventitial progenitor cells. 
Taken together, we postulate that leptin can aggravate neointimal 
formation in mouse vascular injury models by inducing migration of 




























2.1.1 Culture Medium, Recombinant Proteins, Inhibitors and 
Antagonist. 
Table 2.1 Culture medium, recombinant proteins, inhibitors and 
antagonists 
Name  Company  Application 
DMEM ATCC 302002 Cell culture  
DMEM Invitrogen 11960085 Cell culture  
FBS GIBICO 10270 Cell culture 
LIF Merck Millipore 1050 Cell culture  
2-mercaptoethanol GIBCO 21985-023 Cell culture  
Penicillin GIBCO 15140122 Cell culture  
Streptomycin GIBCO 15140122 Cell culture  
L-glutamine GIBCO 25030081 Cell culture  
EmbryoMax EMD Millipore ES-009-B Cell culture  
Leptin Peprotech 450-31 Cell stimulation 
Adiponectin Peprotech 315-26 Cell stimulation 
Visfatin Abcam, ab62617 Cell stimulation 
Resistin Peprotech 450-28 Cell stimulation 
Leptin antagonist Prospec, CYT354 Receptor inhibition 
STAT3 Inhibitor Merckmillipore, WP1066 Pathway inhibition 










Table 2.2 Antibodies. 
Name  Company  Application 
Anti-Sca-1-FITC Abcam, ab25031 FACS, IF 
Anti-CD45-APC-Cy7 Biolegend, 103115 FACS, IF 
Anti-CD29-PE BD Pharmingen, 562801 FACS, IF 
Anti-CD11b-BV785 Biolegend, 101243 FACS 
Anti-CD31-BV510 BD Horizon, 563089 FACS, IF 
Anti-CD140a-APC eBioscience, 17-1401-81 FACS 
Anti- pJAK2 Cell signaling, 3771S WB 
Anti- JAK2 Cell signaling, 3230 WB 
Anti- pSTAT3 Cell Signaling, 9131S WB 
Anti- STAT3 Cell signaling, 4904 WB 
Anti- pERK 1/2 Santa Cruz, sc-16982-R WB 
Anti- ERK 1/2 Cell Signaling, 4695P WB 
Anti- pOBR Invitrogen, PA5-64638 WB, IF 
Anti- OBR Invitrogen, PA1-053 WB, IF, FACS 
Anti- OBR Sigma, HPA030899 IF, FACS 
Anti- pFAK Abcam, ab39967 IF 
Anti- FAK Santa Cruz, sc557 WB, IF 
Anti- GAPDH Santa Cruz, sc25778 WB 
Anti- Sca-1 Abcam, ab25031 IF 
Anti- SMA Sigma, A5228 IF, IHC 
Anti- CD31 Abcam, ab30349 IF 
Anti- leptin Invitrogen, Pa1-051 IF, WB 
Anti- F4/80 Abcam, ab6640 IF 
Anti- CD68 Santa Cruz, sc-9139 IF 
Anti- VE-cadherin Santa Cruz, sc-6458 IF 
Anti- CD117(ckit)-PE eBioscience, 12-1171-82 FACS 
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Anti- CD146-FITC eBioscience, 11-1469-41 FACS 
Anti- Flk1-PE BD Pharmingen, 555308 FACS 
Anti- NG2 Abcam, ab129051 IF, FACS 
 
2.1.3 Experimental Mice  
All animal procedures were approved by the UK Home Office (PPL70/8944). 
C57BL/6J (wild-type) mice were purchased from Harlan, Blackthorn, Bicester, 
UK. RFP mice (Stock No: 005884) and leptin receptor deficient mice (Lepr+/-, 
Stock No: 00697) were purchased from the Jackson Laboratory (Bar Harbour, 
Maine, USA). For Lepr-/- mice, A G to T transversion in the allele causes 
abnormal splicing and a 106 nt insertion in the transcript, leading to the 
premature termination of OBRb, which diminishes its signaling transducing 
function. Male mice aged 10-12 weeks were selected for surgery. All the mice 
were kept 2 to 5 per cage. All mice were kept on a chow diet with autoclaved 
food and water in a pathogen-free and temperature-controlled environment at 
25°C with a 12-hour light and 12-hour dark cycle in the biological service unit 
(BSU) at the James Black Centre of King’s College London. The Lepr+/- mice 















2.2.1 Mouse Adventitial Progenitor Cell Culture 
The procedure used for adventitial progenitor cell culture was similar to that 
described previously (Y. Hu et al., 2004). In brief, the aortic arch and root, as 
well as part of the heart from Lepr+/+ or Lepr-/- mice, were harvested under 
sterile conditions. Adventitial tissues were carefully collected under a 
dissection microscope by removing the aortic media, intima and heart tissue. 
The adventitial tissues were then cut into pieces and seeded onto a 
gelatin-coated T25 flask. The flask was incubated at 37℃, 5% CO2 upside 
down for 2 to 3 hours. After the attachment of adventitial tissues onto the flask, 
complete stem cell medium (Dulbecco's Modified Eagle's Medium 
(DMEM ATCC, 30-2002)) with leukemia inhibitory factor (10 ng/mL, Merck 
Millipore, LIF1050), 2-mercaptoethanol (0.1 mM, GIBCO), 100U/mL penicillin 
(GIBCO), 100U/mL streptomycin (GIBCO) and 2 mM L-glutamine 
(GIBCO) was added for 5 days. When the cells reached 90% confluency, they 
were washed with PBS and trypsinized. The cells were passaged at a ratio of 
1:4 every two or three days. The medium was changed every 2 days.  
 
2.2.2 Sca-1+ Progenitor Cell Isolation and Culture 
When reached 90% confluency, the Sca-1+ adventitial progenitor cells were 
isolated using the Sca-1+ microbeads kit (Miltenyi Biotec, Bergisch Gladbach, 
Germany) according to the manufacturer’s instruction. Briefly, Sca-1+ cells 
were trypsinized and the cell number was then determined by cytometer. The 
cells were centrifuged and resuspended in 90 μL of buffer together with 10 μL 
of anti-Sca-1-FITC per 107 total cells. After 10-minute incubation in the 
refrigerator, the cells were washed, centrifuged and resuspended in 80 μL of 
the buffer with 20 μL anti-FITC microbeads per 107 total cells for 15 minutes. 
After washing, the cells were suspended in 500 μL of buffer and were 
selected using a magnetic cell separator (MACS, Miltenyi Biotec). The 
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column was rinsed with 500 μL of cold buffer, followed by the 500 μL cell 
suspension. Unlabeled cells would pass through the magnetic field, whereas 
Sca-1+ progenitor cells would stay in the column. Finally, the positive cells 
were collected by firmly applying the plunger supplied with the column. The 
Sca-1+ progenitor cells were cultured on 2% gelatin-coated flasks in complete 
stem cell medium (Dulbecco's Modified Eagle's Medium (DMEM ATCC, 
30-2002)) leukemia inhibitory factor (10 ng/mL, Merck Millipore, LIF1050), 
2-mercaptoethanol (0.1 mM, GIBCO), 100 U/mL penicillin (GIBCO), 100 U/mL 
streptomycin (GIBCO) and 2 mM L-glutamine (GIBCO) for both in vitro and in 
vivo studies. 
 
2.2.3 Mouse Vascular Smooth Muscle Cell Culture 
The procedure used for vascular smooth muscle cells’ culture was similar to 
that described previously (Y. Hu et al., 2004). In brief, the aortic arch and root, 
as well as part of the heart from Lepr+/+ or Lepr-/- mice, were harvested under 
sterile conditions. Medial tissues were carefully collected under a dissection 
microscope by removing the aortic adventitia, intima and heart tissue. The 
media was then cut into pieces and seeded onto a 0.04% gelatin-coated T25 
flask. The flask was incubated at 37℃, 5% CO2 upside down for 2 to 3 hours. 
After the attachment of medial tissues onto the flask, complete medium 
(Invitrogen 11960085, Dulbecco's Modified Eagle's Medium, high glucose) 
with 10% fetal bovine serum (GIBICO 10270), 100 U/mL penicillin (GIBCO), 
100U/mL streptomycin (GIBCO) and 2 mM L-glutamine (GIBCO) was added 
for 5 days. When the cells reached 90% confluency, they were washed with 
PBS and trypsinized. The cells were passaged at a ratio of 1:3 every two or 
three days. Medium was changed every 2 days.  
 
2.2.4 Transwell Assay 
Cell migration assessments were performed using transwell inserts with 8.0 
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μm micron pore membrane filters in a 24-well plate (#3422, Corning Life 
Science, USA) as established previously (M. M. Wong et al., 2013). Sca-1+ 
progenitor cells were trypsinized and transferred into the upper chamber at 
105 cells/mL in serum-free media with or without inhibitors. Meanwhile, the 
lower chamber was loaded with 800 μL of serum-free media with treatment 
(Figure 2.1). After 16-hour incubation, the upper side of the filters was 
carefully washed using a cotton bud to remove any non-migratory cells. 
Migratory cells on the underside of the filters were fixed with 4% PFA for 15 
minutes, followed by a 15-minutes staining with 1% crystal violet at room 
temperature. Data shows average cell numbers of migratory progenitor cells 
in 5 random fields at 20x magnification (Figure 2.2). For the experiments 
involving inhibitors or antagonists, Sca-1+ progenitor cells were cultured with 
the respective chemicals in the upper chamber only.  
 





Figure 2.2 Layout of 5 random fields in transwell assay for quantification 
of migrated cells towards chemokines. 
 
2.2.5 Scratch-Wound Assay 
1x104 cells per well of Sca-1+ progenitor cells were seeded in a 12-well plate 
in complete culture media. Once the cells reached 90% confluency, a scratch 
wound was made from top to bottom using a 1 mL pipette tip. The pipette was 
kept at a consistent angle and pressure during the scratch to ensure 
uniformity of width of the scratch. The wells were carefully washed twice 
using PBS to remove any cell debris caused by the “scratch” procedure. 
Treatment and/or inhibitors were added into wells with serum-free media. 
After 16-hour incubation, cells were fixed with 4% PFA and stained with 1% 
crystal violet for 15 minutes at room temperature. The migration of Sca-1+ 
progenitor cells into the “wound” area was evaluated using a phase contrast 
microscope. Data indicated are the mean area occupied by migratory 
progenitor cells in 5 random fields of view at 10x magnification.  
 
2.2.6 RNA Extraction  
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Cells after overnight starvation in serum-free medium were treated with 100  
ng/mL leptin for 5 min, 15 min, 30 min, 1 h and 4 h. Total RNA extraction from 
Sca-1+ progenitor cells was performed with RNeasy Mini kit (#74106, 
QIAGEN Inc.) According to manufacturer’s instruction, cells were washed 
twice with PBS, disrupted by proportional amount of RLT lysis buffer and then 
scraped off from the 6-well plate. The lysate was transferred into a mini 
QIAshredder spin column and centrifuged at full speed for 2 minutes. The 
same volume of 70% ethanol was added to the lysate and the mixture was 
transferred to the RNeasy mini column for a 30-second centrifuge at full 
speed. The flow through was discarded and 700 μL of RW1 was added to 
RNeasy mini column. After 30-second centrifuge, the flow through was 
discarded and 500 μL of RPE was added to the column twice for washing 
away the ethanol. The flow through was then discarded and the column was 
centrifuged within a new collection tube for 2 minutes at full speed to ensure 
no solution outside the column. At last, the RNeasy mini column was 
transferred into a new 1.5 mL RNA-free tube and 40 μL of DEPC water 
(Invitrogen) was added to the membrane of the column, followed by 1-minute 
centrifuge at full speed. The RNA concentration was measured by a 
Nanodrop spectrophotometer ND-1000 (Thermo Scientific, UK) at λ=280nm. 
 
2.2.7 Reverse Transcription (RT) 
Reverse transcription was achieved by QuantiTect Reverse Transcription Kit 
(Qiagen), according to the manufacturer’s instructions (Table 2.3). Briefly, 1 
μg of RNA template, 2 μL of gDNA wipeout buffer and enough volume of 
RNase-free water were mixed in the tube with a total volume of 14 μL. The 
tube was placed in a RT-PCR machine (TECHNE TC-412, Bibby Scientific, 
UK) at 42℃ for 2 minutes, after which 1 μL of RT enzyme, 1 μL of primer mix 
and 4 μL of RT buffer, making up to 6 μL of reaction volume, was added to the 
tube mentioned above. Then the mixture was incubated at 42℃ for 15 
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minutes and subsequently at 95℃ for 3 minutes (Table 2.4). The cDNA 
obtained was diluted into 100 μL by using DEPC-treated water, acquiring a 
final concentration of 10 ng/μL. 
 
Table 2.3 Reverse transcription reaction mix 
Reaction Component  Volume (μL) 
Mix A RNA template x 
gDNA wipeout  2 
RNase-free water 12-x 
Mix B RT buffer 4 
RT enzyme 1 
Primer mix 1 
 
Table 2.4 Reverse transcription program 
Step Temperature (℃) Time (min) 
1 42 2 
2 Pause for Mix B  
3 42 15 
4 95 3 
5 10 - 
 
2.2.8 Quantitative Real-Time Polymerase Chain Reaction 
(qPCR) 
Quantitative real-time PCR was performed by applying SYBR green system 
(#PBOEM20.12, PCR Biosystems). The composition (Table 2.6) and program 
(Table 2.7) are listed below. The target gene was amplified in a duplex in 20 
μL of PCR mixtures (10 μL of Sybr Green, 2 μL of cDNA template, 1.6 μL of  
optimized primers and 6.4 μL of DEPC water) which was loaded into a 96-well 
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plate (Eppendorf White, Eppendorf, UK). The plate was centrifuged at 1000 
rpm for 5 minutes before running the program in qPCR machine. Ct values 
were established using EPPENDORF Mastercycler ep realplex. GAPDH 
served as an endogenous control. Sequences of primer sets used in this 
experiment are listed in Table 2.5.  
 
Primers were designed by using DNA Integrated Technologies (IDT). 
(http://eu.idtdna.com/scitools/Applications/RealTimePCR/) 
  
Table 2.5 Primers used in qPCR 
 
Name Sequence NCBI 
reference  
LEPR 5’>AGCAACTGCATCTCCAGTAATC<3’     NM_146146.2 
  5’>GTGGGTTGCTGGTCTGATAAA<3’ 
SM22 5’>GATATGGCAGCAGTGCAGAG<3’     NM_011526.5 
 5’>AGTTGGCTGTCTGTGAAGTC<3’;  
 Calponin 5’>GGTCCTGCCTACGGCTTGTC<3’ XM_011242388.2 
  5’>TCGCAAAGAATGATCCCGTC<3’      
ADIPOR1 5’>TGTACCCACCATGCACTTTAC<3’           NM_028320.4 
  5’>CATCACAGCCATGAGGAAGAA<3’ 
ADIPOR2 5’>GTATCCCTGAGCGCTTCTTT <3’            NM_197985.3 
 5’> GACTCCGTGGAAGTGAACAA <3’ 
 CCR1 5’> CATTGTCCATGCTGTGTTTGCCCT <3’    NM_009912.4 
  5’>TCTTCCACTGCTTCAGGCTCTTGT <3’ 
CCR2 5’> ATCACCATTACACCTGTGGCCCTT <3’   XM_011243064.2 
 5’> AGCCCTGTGCCTCTTCTTCTCATT <3’ 
CCR7  5’> TCATTGCCGTGGTGGTAGTCTTCA <3’  NM_001301713.1 
 5’> ATGTTGAGCTGCTTGCTGGTTTCG <3’ 
CCR9 5’> TTGTGTTCATTGTGGGCACCTTGG <3’  NM_001166625.1 
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 5’> CATCCATTGACCAGCAGCAGCAAT<3’ 
CXCR3 5’>TGTAGCCCTCACCTGCATAGTTGT<3’ NM_009910.3 
  5’>GTTGTACTGGCAATGGGTGGCATT <3’ 
CXCR4 5’>AGCTAAGGAGCATGACGGACAAGT<3’  XM_006529113.3 
  5’>AACGCTGCTGTAGAGGTTGACAGT<3’ 
CXCR5 5’>AAGCGGAAACTAGAGCCTGGTTCA<3’  NM_007551.2 
  5’>ACCATCCCATCACAAGCATCGGTA<3’ 
GAPDH  5’>CATGTTCGTCATGGGTGTGAACCA <3’  NM_001289726.1 
 5’>ATGGCATGGACTGTGGTCATGAGT<3’ 
  
Table 2.6 qPCR reaction mix 
 Component Volume (μL) 
Master Mix 2x SYBR green 10 
10 μM primers 1.6 
DEPC-water 6.4 
 10ng/μL cDNA 2 
 
Table 2.7 qPCR reaction program 
Step Temperature (℃) Time (min:sec) Note 
1 95 10:00  
2 95 00:15 Repeat step 2 to 3 for 40 
cycles 3 60 01:00 
4 95 00:15 Build up the melting curve 
for the primers respectively 5 60 00:15 
6 - 20:00 
7 95 00:15 
 
2.2.9 Conventional Polymerase Chain Reaction (PCR) 
Conventional polymerase chain reaction was performed in this project for the 
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identification of specific mice, such as RFP mouse and Lepr-/- mouse. 50 ng of 
cDNA was amplified to the corresponding DNA by applying Taq DNA 
polymerase (#1034253, Invitrogen). The PCR components (Table 2.9) and 
program (Table 2.10) are showed below. The products were transferred into 2% 
agarose gel and observed by the Biospectrum AC Imaging system and Vision 
worksLS software. Sequences of all primers for the identification of mice were 
provided by Jackson laboratory, USA. The sequences of the primers are 
listed in Table 2.8.  
 
Table 2.8 primers used in conventional PCR 
RFP 5’> CCCCGTAATGCAGAAGAAGA<3’   NC_000072.6 
 5’> CTTGGCCATGTAGGTGGTCT <3’ 
db/db 5’> AGAACGGACACTCTTTGAAGTCTC<3’  XM_017320002.1 
 5’> CATTCAAACCATAGTTTAGGTTTGTGT<3’ 
 
Table 2.9 PCR reaction mix 
Components Volume(μL) 
10x PCR buffer 1.20 
50mM MgCl2 0.96 
25mM dNTPs 0.96 
20 μM Forward Primer 0.6 
20 μM Reverse Primer 0.6 
5 U/μL Taq DNA Polymerase 0.06 
RNase-free H2O 5.62 
10 ng/μL cDNA 2 
 
Table 2.10 PCR reaction program 
Step Temperature (℃) Time (min:sec)  
1 94 01:30  
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2 94 00:30 repeat steps 2-4 
for 35 cycles 3 52 00:45 
4 72 00:45 
5 72 02:00  
6 10  hold 
 
2.2.10 Agarose Gel Preparation and Observation 
2 g of agarose powder (#16500500, Invitrogen) was added in 100 mL 1x TAE 
buffer (#EC872, National Diagnostic). The mixture was heated to boiling in a 
microwave for two minutes. Once the agarose cools down to around 60℃, 10 
μL of SafeView nucleic acid stain (#NBSSV, NBS Biologicals) was added into 
the solution. The gel mixture was gently poured into a Horizon ® horizontal gel 
cast electrophoresis apparatus with the well comb inside. Once the gel 
reached room temperature and solidified, the gel was gently placed in the 1x 
TAE buffer and the comb was carefully removed. 25 μL of amplified DNA 
samples together with 5 μL of 6x loading buffer were loaded into each well. 
Electrophoresis was performed at 160 V for 20 minutes. DNA fragments were 
visualized under UV light by using Biospectrum Imaging System 500. 
 
2.2.11 Phenotyping of Cultured Sca-1+ Progenitor Cells and 
Smooth Muscle Cells 
Cells were isolated from the adventitial of Lepr+/+ and Lepr-/- (db/db) mice, and 
kept growing for few passages. The heterogeneous Sca-1+ adventitial cells 
were purified by applying anti-Sca-1 microbeads. Flow cytometry was 
performed within 3 passages after sorting. Cultured lepr+/+ and Lepr-/- Sca-1+ 
progenitors were harvested by using scraptase (GenDEPOT, CA110-010). 
Cells were then centrifuged and resuspended in cold PBS, followed by a 
30-minute staining on ice with following antibodies: Anti-Sca-1-FITC (clone 
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D7, abcam, ab25031), Anti-CD45-APC-Cy7 (clone 30-F11, biolegend, 
103115), Anti-CD29-PE (clone HMβ1-1, BD Pharmingen, 562801), 
Anti-CD11b-BV785 (clone M1/70, biolegend, 101243), Anti-CD31-BV510 
(clone MEC13.3, BD Horizon, 563089), Anti-CD140a-APC (clone APA5, 
eBioscience, 17-1401-81). Cells were analyzed with BD Accuri C6 or BD LSR 
Fortessa II (Becton Dickinson) flow cytometers.  
 
2.2.12 Protein Extraction 
Femoral artery or Sca-1+ progenitor cells with or without treatment were lysed 
using RIPA buffer (#89901, Life Tech) with phosphatase inhibitor tablets 
(#04906845001, Roche) and protease inhibitors (#11873580001, Roche). 
The lysate was sonicated using a Branson Sonifier 150 at level 1 for 8 
seconds twice before 45-minute incubation on ice. The lysate was then 
centrifuged at 15000 g for 10 minutes at 4 ºC. The supernatant was collected 
and transferred to a new 1.5 mL tube. The concentration of proteins was 
measured by performing Biorad Protein Assay (#5000006, BIO-RAD). 2 μL of 
the protein lysate was added to 998 μL of the 1x Bio-rad reagent. After 
10-minute incubation at room temperature, the protein concentration of 
mixture was evaluated by using the Bio-rad spectrophotometer 3000. 2 μL of 
RIPA buffer was used as a blank. 
 
2.2.13 Western Blotting Analysis 
20 μg of lysate mixed with 5xSDS loading buffer was heated at 95℃ for 15 
minutes before loaded into a NuPage 4-12% Bis Tris-gel (#NP0335BOX, 
Novex) immersed in NuPage MOPS SDS running buffer, followed by 
standard Western blotting procedures. Briefly, Electrophoresis was performed 
at 160V for 1.5 hours. The gel was then transferred onto a nitrocellulose 
membrane in XCellTM Blot module (Invitrogen) at 35 V for 60 minutes. The 
membrane was then blocked with 5% milk in TBS-T (0.1% Tween, 
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Sigma-Aldrich) for 1 hour at room temperature, followed by 1-hour incubation 
with primary antibodies overnight at 4 ºC. After three washes, the 
corresponding secondary antibody diluted in 5% milk TBS-T was added to the 
membrane for 60 minutes at room temperature. After three washes, the 
membrane was reacted with AmershamTM ECLTM (RPN2106, Invitrogen) 
Western Blotting Detection Reagents (GE Healthcare) for 2 minutes at room 
temperature. Film (Amersham, Kodak) was exposed in the dark room by 
applying Compact X4 developing machine (Xograph Imaging System). 
Primary antibodies against pJAK2 (Cell signaling, 3771S), JAK2 (Cell 
signaling, 3230), pSTAT3 (Cell Signaling, 9131S), STAT3 (Cell signaling, 
4904), pERK 1/2 (Santa Cruz, sc-16982-R), ERK 1/2 (Cell Signaling, 4695P), 
pOBR (Invitrogen, PA5-64638), OBR (Invitrogen, PA1-053), pFAK (Abcam, 
ab39967), FAK (Santa Cruz, sc557) and GAPDH (Santa Cruz, sc25778) were 
used to detect the respective proteins.  
 
2.2.14 MAPK Pathway Phosphorylation Array 
The detection of phosphorylated MAPK-related protein was performed by 
using MAPK pathway phosphorylation array (AAHMAPK1-4, RayBiotech). 
The proteins of cells with or without treatment were collected by applying lysis 
buffer provided in the kit. The concentration of cell lysate was measured by 
using detection buffer provided in the kit. Array membrane was put into a well 
of the incubation tray and incubated in blocking buffer for 30 minutes at room 
temperature. Discard the blocking buffer and pipette 1mL of diluted sample 
into each well and incubate for 2 hours at room temperature. After two 
washes, added 1 mL of the well-mixed detection antibody cocktail into each 
well for 2 hours at room temperature. After two washes, 2 mL of 1x 
HRP-Anti-Rabbit IgG was added to each well for 2 hours at room temperature. 
After two washes, the membrane was well cleaned and incubated with 500 μL 
of the well-mixed detection buffer for 2 minutes at room temperature. The 
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membrane was analyzed by applying an X-ray film or a chemiluminescence 
imaging system. The proteins detected in this array were listed in Table 2.3. 
 
 
Figure 2.3 layout of MAPK proteins array 
 
2.2.15 G-LISA RhoA/Rac1/Cdc42 Activation Assay 
The activation of GTPase family was determined by performing G-LISA 
RhoA/Rac1/Cdc42 Activation Assay (Cytoskeleton, Inc. #BK135) according to 
the standard protocol provided by manufactory. Briefly, cells were seeded and 
grown to 70% confluency, followed by the stimulation with leptin from 2 to 30 
minutes. Cells were collected and lysed on ice and the concentration of cell 
lysate was measured by using the detection solution provided in the kit. After 
adding buffer blank and buffer positive control, 50 µl of equalized lysate were 
added to duplicate wells in an incubation plate. The plate was immediately 
placed on an orbital shaker at 400 rpm for 15 (Rac1 and Cdc42) or 30 (RhoA) 
minutes in the cold room. After two washes, 200 µl of room temperature 
Antigen Presenting Buffer was added to each well at room temperature for 2 
minutes. After three washes, 50 µl of diluted anti-RhoA/Rac1/Cdc42 primary 
antibody was added to each well on an orbital shaker at 400 rpm for 30 (Rac1 
and Cdc42) or 45 (RhoA) minutes at room temperature, followed by the 
incubation of 50 µl of diluted secondary antibody to each well for 30 (Rac1 
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and Cdc42) or 45 (RhoA) minutes at room temperature. After three washes, 
50 µl of the mixed HRP detection reagent was added into each well at 37°C 
for 10 to 15 min, the reaction of which was stopped by administration of 50 µl 
of HRP Stop Buffer. The absorbance was measured at 490 nm by using a 
microplate spectrophotometer. Buffer blank was designated as assay blank. 
 
2.2.16 Mouse Leptin ELISA 
The concentration of serum leptin was measured by applying Mouse/Rat 
Leptin Quantikine ELISA Kit (R&D systems, # MOB00) according to the 
standard protocol provided by manufactory. Briefly, blood from wild-type and 
db/db mice was collected and allowed to clot for 2 hours at room temperature 
before centrifuging for 20 minutes at 2000g. Serum was collected and diluted 
20 times for assays. ELISA microplate strips was firstly added 50 μL of Assay 
Diluent RD1W for each well. 50 μL of standard, control, or samples were then 
added to each well and incubated for 2 hours at room temperature. After five 
washes, 100 μL of Mouse/Rat Leptin Conjugate was added to each well for 
2-hour incubation at room temperature. Repeat the washing procedure and 
add 100 μL of Substrate Solution to each well for 30 minutes at room 
temperature away from the light. 100 μL of Stop Solution was finally added to 
each well and the absorbance was determined by using a microplate reader 
set to 450 nm within 30 minutes. The absorbance at 540 nm or 570 nm was 
used as wavelength correction.  
 
2.2.17 Immunofluorescence Staining and En Face Preparation 
Frozen sections were fixed with 4ºC acetone and permeabilized with 0.1% 
Trixton X-100 in PBS for 30 minutes at room temperature. For En Face 
staining, tissues were fixed with 4% paraformaldehyde for 15 minutes and 
then permeabilized with 0.5% Trixton X-100 in PBS for 30 minutes. For cell 
staining in chamber slides (BD Biosciences), the cells were fixed with 4% 
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paraformaldehyde for 15 minutes and then permeabilized with 0.1% Trixton 
X-100 in PBS for 30 minutes. Tissues or cells were blocked in 5% swine 
serum for 45 minutes at room temperature prior to their incubation with 
primary antibodies for either 1 hour at 37 ºC or overnight at 4 ºC. After three 
washes with PBS, secondary antibodies were administered for 45 minutes at 
37 ºC, followed by DAPI (1:5000 in PBS) staining for 5 minutes at room 
temperature. Frozen section or cells in chamber slides were mounted with 
fluorescence mounting medium (Dako). For En Face preparation, after the 
staining with DAPI the vessel was cut open along the long axis with the lumen 
facing up (Zou et al., 2000). The opened vessels were then transferred onto a 
clean slide and mounted with fluorescence mounting media (Vectashield). A 
confocal microscope (Leica SP5) and AxioVision Digital Imaging System 
(Carl Zeiss Ltd) were used for image acquisition. Primary antibodies applied 
in the present study were Sca-1 (Abcam, ab25031), αSMA (Sigma, A5228), 
CD31 (Abcam, ab30349), leptin (Invitrogen, Pa1-051), F4/80 (Abcam, 
ab6640), CD68 (Santa Cruz, sc-9139), VE-cadherin (Santa Cruz, sc-6458) 
and RFP (Abcam, ab62341). Corresponding fluorescent-conjugated IgG 
antibodies were used as secondary antibodies. Slides stained with secondary 
antibodies only served as a binding control. 
 
2.2.18 Histological Analysis 
Femoral artery was fixed with 4 % formalin overnight at 4°C prior to a 
machine-based dehydration. The dehydrated samples were embedded in 
paraffin and subsequently cut into 5 µm sections. H&E staining was 
performed using a standard protocol with Hematoxylin and Eosin for 
morphology analysis.  
 
2.2.19 Cell Proliferation ELISA, BrdU 
BrdU assay was performed using cell proliferation ELISA kit (Roche, 
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11669915001) according to a standard protocol provided by manufactory. 
Briefly, cells were cultured with leptin for different time points and then 
labelled with BrdU for 2 hours in a humidified atmosphere at 37°C. Incubation 
with Fixdenat solution and anti-BrdU POD were subsequently performed. 
After three washes, substrate reaction was added to each well, and the 
absorbance was measured at 450 nm with microplate reader. 
 
2.2.20 RFP Labelling Cells 
Lentiviral particles were generated by transfecting HEK293T cells with LV 
H2b_RFP plasmid (Addgene, 26001) and used to label the nucleus of 
adventitial cells. Sca-1+ progenitor cells were incubated with RFP lentivirus 
for 10 minutes, and the waste was carefully disposed. Expression of RFP was 
checked using a fluorescent microscope two days after the treatment with 
lentivirus. 
 
2.2.21 Phenotyping of Cultured Sca-1+ Progenitor Cells And 
Smooth Muscle Cells 
Cells were isolated from the adventitial of Lepr+/+ and Lepr-/- (db/db) mice, and 
kept growing for few passages. The heterogeneous Sca-1+ adventitial cells 
were purified by applying anti-Sca-1 microbeads. Flow cytometry was 
performed within 3 passages after sorting. Cultured lepr+/+ and Lepr-/- Sca-1+ 
progenitors were harvested by using scraptase (GenDEPOT, CA110-010). 
Cells were then centrifuged and resuspended in cold PBS, followed by a 
30-minute staining on ice with following antibodies: Anti-Sca-1-FITC (clone 
D7, abcam, ab25031), Anti-CD45-APC-Cy7 (clone 30-F11, biolegend, 
103115), Anti-CD29-PE (clone HMβ1-1, BD Pharmingen, 562801), 
Anti-CD11b-BV785 (clone M1/70, biolegend, 101243), Anti-CD31-BV510 
(clone MEC13.3, BD Horizon, 563089), Anti-CD140a-APC (clone APA5, 
eBioscience, 17-1401-81), CD105-PE (clone MJ7/18, BioLegend, 120407), 
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CD117(ckit)-PE (clone 2B8, eBioscience, 12-1171-82), CD146-FITC (clone 
P1H12, eBioscience, 11-1469-41), Flk1-PE (clone AVAS 12α1, BD 
Pharmingen, 555308), anti-NG2 antibody (rabbit polyclonal, Abcam, 
ab129051), anti-Lepr (rabbit polyclonal, Sigma, HPA030899). Cells stained 
with secondary control only were used as negative control. Cells were 
analyzed with BD accuri C6 or BD LSR fortessa II (Becton Dickinson) flow 
cytometers.  
 
2.2.22 Van Gieson Staining 
Slides were underwent deparaffin and rehydration, following the immersion in 
32 mmol/L of potassium permanganate for 10 minutes. After rinsing in dH2O, 
the slides were immersed in 70 mmol/L of oxalicacid dehydrate for 5 minutes, 
washing in several changes of dH2O. The slides were again rinsed in 70% 
ethanol, followed by a 3-hour incubation in Miller’s stain. After rinsing in 70% 
ethanol and dH2O, the slides were incubated in Van Gieson solution for 5 
minutes. After washing in dH2O, the slides were dried and mounted with 
mounting medium. 
 
2.2.23 Mouse Femoral Artery Denudation Injury and Cell 
Delivery 
The procedure used for the mouse model is similar to that established 
previously (Zeng et al., 2006). Wild-type or leptin receptor deficient mice 
(db/db) were anesthetized with ketamine and medetomidine hydrochloride. A 
groin incision was made under a surgical microscope. An arteriotomy was 
made in the epigastric branch of femoral arteries. A 0.014’ guide wire 
(Hi-Torque, Cross-it 200XT) was inserted into the femoral artery above the 
bifurcation of the abdominal aorta. The guide wire was gently pulled back and 
forth three times, leading to the endovascular injury of the arteries. After the 
removal of the guide wire, the femoral artery was ligated. Sham-injury arteries 
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without passage of the guide wire were used as a control. After the injury, 
1×106 (RFP) progenitor cells with or without treatment in 30 μL of Matrigel 
Basement Membrane Matrix per artery were delivered to the adventitial side 
of injured artery. The arteries were harvested on days 7, 14 or 28 
post-surgery for En Face, frozen section or paraffin sections. The areas of 





Figure 2.4 Image pro plus was applied for graph analysis. Opened the 
image by “image pro plus 6.0”; used irregular wand to draw the outlines of 
lumen (A), internal elastic lamina (B) and external elastic lamina (C); 
calculated the areas of three circles. Three different circles were built. B-A 
standed for neointima area and C-B meant media area. (Neointima area / 
medial area,I/M) = (B-A) / (C-B) and (medial area percentage）=（C-B) / C 
   
2.2.24 Immunohistochemical Staining 
The procedure used in present study is similar to that established previously 
(Zeng et al., 2006). Immunohistochemistry was achieved by using Vectastain 
ABC HRP kit (Vector laboratories, PK-6100). Briefly, praffin sections were 
incubated with αSMA (Sigma, A5228, 1:200) primary antibody for 1 hour at 
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room temperature after fixation and blocking. Diluted biotinylated secondary 
antibody was then applied for 30 minutes at room temperature. After washing, 
sections were incubated in peroxidase substrate solution until desired stain 
intensity showed up. The sections were then rinsed, counterstained, cleared 
and mounted. 
 
2.2.25 Statistical Analysis 
Data represented as the mean and standard error of the mean (S.E.M.) of at 
least three individual experiments. Data were analyzed using Graphpad 
Prism 6 with unpaired and two-tailed Student’s t-test. For data involved in 
more than two groups, ANOVA test was applied followed by Dunnett’s 
multiple comparison test. The mean of each column with different treatments 
was compared to the mean of the column named either “Ctr”, “Control” or “0”.. 






































3.1 The Migration of Sca-1+ Adventitial Progenitor 
Cells Could Be Inhibited or Induced by Different 
Adipokines. 
Obesity leads to changes in the levels of plasma adipokines such as 
adiponectin, leptin, visfatin, and resistin, all of which may influence 
cardiovascular system. To determine whether Sca-1+ progenitors could 
respond to these adipokines, migratory assays including transwell (Figure 
3.1A) and wound-healing (Figure 3.1B) in response to different adipokines 
were performed. Our data demonstrated that 16-hour treatment of 100 ng/mL 
leptin and 10 ng/mL resistin could significantly induce the chemotaxis of 
Sca-1+ progenitor cells in transwell assay and migration in wound-healing 
assay. However, Sca-1+ progenitor cells displayed a reduced migration in 
response to 10 ng/mL adiponectin. It is well established that leptin receptor b 
played a crucial role in leptin-induced cell response, whereas the identity of 
the receptors of resistin are still under debate. Single cell transcriptome 
analysis of Sca-1+ progenitor cells (data not shown, in press) in the previous 
study from our lab revealed that Sca-1+ progenitor cells from both wild-type 
and apoE-/- mice expressed leptin receptor b (OBR). Since the migration of 
Sca-1+ progenitor cells contributes to vascular remodeling, the relationship 






Figure 3.1. The migration of Sca-1+ adventitial progenitor cells could be 
inhibited or induced by different adipokines. A, Chemotaxis of Sca-1+ 
progenitor cells in response to 10 ng/mL adiponectin (n=3), 10 ng/mL resistin 
(n=3) and 100 ng/mL leptin (n=6) was evaluated by applying 1% crystal violet 
staining after 16-hour incubation (scale bars, 50 µm). B, Migration of Sca-1+ 
progenitor cells in response to 10 ng/mL adiponectin (n=3), 10 ng/mL resistin 
(n=3) and 100 ng/mL leptin (n=6) was documented by using an 8.0 µm 
transwell system. Serum-free cultured medium and dimethyl sulfoxide 















3.2 Leptin Enhanced the Migration of Sca-1+ 
Progenitor Cells 
To investigate whether leptin was involved in the migration of Sca-1+ 
adventitial progenitor cells, we performed an in vitro transwell assay. 1*106 
Sca-1+ progenitor cells after sorting were transferred into upper chamber for 
the incubation of different time length with 100 ng/mL leptin in the bottom 
chamber. Cell numbers on the underside of the transwell membrane were 
counted after staining with 1% crystal violet. We found that treatment with 100 
ng/mL of leptin markedly induced the chemotaxis of Sca-1+ progenitor cells in 
a time-dependent way with a peak of migratory difference after 16-hour 
incubation (Figure 3.2A and B). Therefore, we performed following migratory 
assays for an incubation of 16 hours with different concentration of leptin. Our 
data indicated that leptin could substantially induce the chemotaxis of Sca-1+ 
progenitors in a dose-dependent manner (Figure 3.3A and B), with maximal 
chemotaxis at 100 ng/mL of leptin after 16-hour incubation. Wound healing 
assay also allows researchers to study cell migration. Consistent with the 
results in transwell assay, we confirmed that leptin could also induce the 
migration of Sca-1+ progenitor cells in wound-scratch assays especially at 
high concentration of leptin (Figure 3.4A and B). Taken together, leptin could 








Figure 3.2. Leptin can induce the migration of Sca-1+ adventitial 
progenitor cells in a time-dependent manner. A, Chemotaxis of Sca-1+ 
progenitor cells at different time points with or without the treatment of 100 
ng/mL recombinant leptin was documented by using an 8.0 µm transwell 
assay (n=4). B, The ratio between control and leptin-treated group was 
analyzed at each time point (n=4). Serum-free cultured medium without leptin 
treatment was used as a control for the migration assays above. Migration 
index for transwell assays was defined as the mean ratio of treatment to 
control of cell numbers counted per 5 random fields at 20X magnification. 
Fold change represented the ratio of the number of cells in experimental 
groups compared to control. All graphs are shown as mean ± SEM. *p<0.05, 




Figure 3.3. Leptin can induce the chemotaxis of Sca-1+ adventitial 
progenitor cells in a dose-dependent manner. A and B, Chemotaxis of 
Sca-1+ progenitor cells in response to an increasing gradient of leptin in an 
8.0 µm transwell system was identified by applying 1% crystal violet staining 
after 16-hour incubation (scale bars, 50 µm, n=6). Serum-free cultured 
medium without leptin treatment was used as a control for the migration 
assays above. Migration index for transwell assays was defined as the mean 
ratio of treatment to control of cell numbers counted per 5 random fields at 
20X magnification. Fold change represented the ratio of the number of cells in 
experimental groups compared to control. All graphs are shown as mean ± 





Figure 3.4. Leptin can induce the migration of Sca-1+ adventitial 
progenitor cells in a time-dependent manner. A and B, Migration of Sca-1+ 
progenitor cells in response to an increasing gradient of leptin after 16-hour 
incubation was evaluated in a scratch assay by following crystal violet 
staining (scale bars, 100 µm, n=6). Serum-free cultured medium without 
leptin treatment was used as a control for the migration assays above. 
Migration index for scratch assays was defined as the mean ratio of treatment 
to control of migrated area counted per 5 random fields at 10X magnification. 
Fold change represented the ratio of the number of cells in experimental 





3.3 Leptin Did Not Enhance the Proliferation of Sca-1+ 
Progenitor Cells 
Although transwell and wound-healing assays demonstrated promising 
results of leptin-induced cell migration, higher numbers of cells could also be 
caused by cell proliferation. To assess the potential effect of leptin on cell 
proliferation during migratory assays, BrdU assay was performed. Data 
demonstrated that leptin could not enhance the proliferative ability of Sca-1+ 
progenitor cells 16 hours after treatment (Figure 3.5A). There is no difference 
between the groups even in cells stimulated with high concentrations of leptin. 
Taken together, leptin could increase the chemotaxis and migration of Sca-1+ 
progenitor cells in vitro, particularly at a high concentration of 100 ng/mL. 
Therefore, subsequent experiments including G-LISA, qPCR, Western 
blotting and immunofluorescent staining were performed with a concentration 











Figure 3.5. Leptin cannot induce the proliferation of Sca-1+ adventitial 
progenitor cells. A, Proliferation of Sca-1+ progenitor cells was examined by 
BrdU assay after 16-hour incubation with leptin (n=6). Serum-free cultured 
medium without leptin treatment was used as a control for the proliferation 













3.4 Sca-1+ Progenitor Cells Expressed Leptin 
Receptor 
Leptin receptors have six isoforms but only leptin receptor b (OBR) is 
considered to functionally transduce downstream signals. Since leptin could 
induce the migration of Sca-1+ progenitor cells, the existence of OBR was 
analyzed in Sca-1+ progenitor cells isolated from the adventitia of the aortas 
of C57BL/6J mice. Although we had data from single cell transcriptome 
analysis showing the expression of Lepr on Sca-1+ progenitor cells, we still 
further confirmed the expression of OBR on Sca-1+ progenitor cells by 
conventional PCR (Figure 3.6A and B) and Western blotting analysis (Figure 
3.6C and D). The expression of OBR was not upregulated in response to 100 
ng/mL of leptin at either RNA or protein levels. The existence of OBR+ / 
Sca-1+ adventitial cells was also identified by performing the immunostaining 
of aorta (Figure 3.7A) and femoral artery (Figure 3.7B) from wild-type mouse. 
We also performed immunostaining with CD29, CD34, CD45, Sca-1 and OBR 
primary antibodies on the Sca-1+ progenitor cells which had migrated on the 
lower side after transwell assays. After the fixation with 4% PFA for 15 
minutes, the membrane was cut into small pieces and pasted to a slide, 
followed by a standard protocol of immunofluorescence. The presence of 
OBR and Sca-1 (Figure 3.8A) was again confirmed. We also discovered that 
Sca-1+ progenitor cell which had migrated in response to leptin could express 
CD29 (Figure 3.8B) and CD34 (Figure 3.8C) but not CD45 (Figure 3.8D). 
Thus, we confirmed that Sca-1+ progenitor cells expressed leptin receptor as 







Figure 3.6. Leptin could not increase the expression of OBR on Sca-1+ 
adventitial progenitor cells. A and B, The presence of leptin receptor b 
(OBR) in Sca-1+ progenitor cells was confirmed by performing conventional 
PCR (n=4). C and D, The presence of leptin receptor b (OBR) in Sca-1+ 
progenitor cells was confirmed by Western blotting (n=7). Untreated cells 
served as a control. Images shown are representative of at least 3 





Figure 3.7. Sca-1+ OBR+ cells reside mainly in the adventitia of aorta and 
femoral artery. A, Cross sections of aorta from wild-type were analyzed by 
immunofluorescence for Sca-1 and OBR (scale bars, 100 and 50 µm, n=4). 
Red arrow indicated Sca-1+ OBR+ adventitial cells. White arrow indicated 
Sca-1+ OBR+ medial cells. Purple arrow indicated Sca-1+ OBR+ endothelial 
cells. B, Cross sections of femoral artery from wild-type mice were analyzed 




Figure 3.8. The expression of progenitor markers in leptin-induced 
migrated cells. Migrated cells after trans well assay were analyzed by 
immunofluorescence for Sca-1(A), CD29 (B), CD34(C), CD45(D), and OBR 
(scale bars, 50 µm, n=3). Images shown are representative of at least 3 












3.5 Absence of OBR Did Not Affect the Nature of 
Sca-1+ Progenitor Cells  
To further investigate the role of OBR in Sca-1+ progenitor cells, the adventitia 
of aorta of confirmed db/db mice was harvested for the isolation of Lepr-/- 
Sca-1+ progenitor cells. Conventional PCR was performed to confirm the 
genotype of db/db mice using the primers and protocols provided by Jackson 
laboratory (Figure 3.9A). Uninjured femoral arteries from either wild-type or 
db/db mice were harvested. Immunostaining of frozen section of femoral 
arteries from db/db (Figure 3.9C) and wild-type (Figure 3.9B) mice confirmed 
that the femoral arteries from db/db mice did not show any expression of 
leptin receptor in femoral artries and that Sca-1+ cells showed a similar 
distribution in the vascular wall of db/db and wild-type mice. Data 
demonstrated that OBR expressed in all three layers of femoral artery in 
wild-type mice, whereas Sca-1 mainly expressed in the intima and adventitial 
in both wild-type and db/db mice. There was no difference for the expression 
of Sca-1+ progenitor cells between wild-type and db/db mice before vessel 
injury (Figure 3.10A, B and C). However, a significant reduction of the 
expression of Sca-1+ progenitor cells was observed in db/db mice 
post-surgery (Figure 3.10D), indicating that the migratory ability of Lepr-/- cells 
may be impeded in vivo. To investigate whether the absence of OBR affects 
the phenotype of Sca-1+ progenitor cells, we performed flow cytometry for 
hematopoietic, mesenchymal and progenitor markers on Lepr+/+ and Lepr-/- 
Sca-1+ progenitor cells. Data revealed that there were no differences in the 
expression of any markers between Lepr+/+ (Figure 3.11 and 3.12A) or Lepr-/- 
(Figure 3.11 and 3.12B) adventitial progenitor cells. Both Sca-1+ progenitor 
cells populations were negative for hematopoietic markers CD45 and CD11b, 
endothelial marker CD31, excluding the possibilities that Sca-1+ progenitor 
cells originated from endothelium or bone marrow. Moreover, data showed 
similar staining for CD29 (99.9%) and CD140a (99%). Collectively, our results 
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showed that the absence of OBR from db/db mice either did not affect Sca-1+ 
progenitor cells phenotypic characteristics. 
 
 
Figure 3.9. The identification of Lepr-/- mice was achieved by applying 
conventional PCR and immunostaining. A, Conventional PCR was 
performed for the identification of every Lepr-/- mice (n=29). B, Cross sections 
of uninjured femoral artery from wild-type were analyzed by 
immunofluorescence for αSMA, Sca-1 and lepr (scale bars, 50 µm, n=4). C, 
Cross sections of uninjured femoral artery from db/db were analyzed by 




Figure 3.10. The quantification of Sca-1+ cells two weeks after vessel 
injury was analyzed in db/db and wild-type. A, Cross sections of injured 
femoral artery from wild-type were analyzed by immunofluorescence for 
Sca-1 (scale bars, 50 µm, n=4). B, Cross sections of injured femoral artery 
from db/db were analyzed by immunofluorescence for Sca-1 (scale bars, 50 
µm, n=4). C, The semi-quantification of number of Sca-1+ adventitial cells was 
evaluated in wild-type mice before and two weeks post-surgery (n=4). D, The 
semi-quantification of number of Sca-1+ adventitial cells was evaluated in 
db/db mice before and two weeks post-surgery (n=4). All graphs are shown 






Figure 3.11. Phenotype of wild type and Lepr KO of Sca-1+ adventitia 
progenitor cells. Cells were originated from either wild-type or db/db mice. A, 
Phenotype of wild type Sca-1+ adventitia progenitor cells with primary 
antibodies of CD45, CD11b, CD31, CD29, CD140a and Sca-1. B, Phenotype 
of Lepr-/- Sca-1+ adventitia progenitor cells with primary antibodies of CD45, 





Figure 3.12. Phenotyping of Lepr+/+ and Lepr-/- of Sca-1+ adventitia 
progenitor cells. A, Phenotyping of Lepr+/+ Sca-1+ adventitia progenitor cells 
with primary antibodies of CD29, CD34, CD105, c-kit, CD146 and Kdr. B, 
Phenotyping of Lepr-/- Sca-1+ adventitia progenitor cells with primary 





3.6 OBR-STAT3-MAPK Pathways and Rho GTPase Are 
Activated in Sca-1+ Cells in Response to Leptin 
To understand the underlying mechanism behind the Sca-1+ progenitor cells 
migration in response to leptin, we next sought to elucidate OBR downstream 
signaling pathways. Sca-1+ progenitor cells were starved overnight in 
serum-free medium, prior to the treatment with 100ng/mL of leptin for different 
time points. Cells were then collected by scrapers and protein lysis buffer for 
western blotting assays. The signaling pathways of leptin were 
well-established in other types of cells. The activation of STAT3 is known to 
be important steps in leptin-induced migration in other cell types, such as 
breast cancer cells and liver cancer cells (Dieudonne et al., 2002; Saxena et 
al., 2007). Treatment with 100 ng/mL of leptin for different time points 
demonstrated that phosphorylation STAT3 was activated from 5 minutes and 
reached maximal expression 15 minutes after treatment (Figure 3.13A and 
B). 
MAPK/MEK/ERK pathway belongs to the well-defined Ras/Raf/MAPK 
signaling cascade, which can be activated by numerous stimuli including 
leptin. Previous studies showed that leptin could participate in the apoptosis 
of osteoblastic progenitor lineage, the migration of endothelial cells and the 
hypertrophy of vascular smooth muscle cells via ERK 1/2 signaling pathway 
(Zeidan et al., 2005). However, the role of this pathway in adventitial 
progenitor cells remained unknown. Our data showed that pERK1/2 and 
pMEK1/2 were activated within 5 minutes after the treatment in adventitial 
progenitor cells, without any change in total MEK1/2 (Figure 3.17A and C) 
and ERK1/2 (Figure 3.13C and D).  
Rho GTPase family members have been reported as critical factors for cell 
migration.(Horwitz & Parsons, 1999) To elucidate whether RhoA, Cdc42 or 
Rac1 were involved in Sca-1+ progenitor cell leptin-induced migration, G-LISA 
activity assay was performed which was, in comparison to pull-down assay, a 
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novel and efficient approach to quantify the activation of GTPase family. 
Treatment with 100 ng/mL of leptin led to the early activation of Cdc42 (Figure 
3.14A) and Rac1 (Figure 3.14B) within 5 minutes but not of RhoA.  
Vinculin is a member of cytoskeleton anchoring in F-actin protein. Vinculin is 
involved in linking integrin adhesion molecules to the actin cytoskeleton, 
associated with cell-cell and cell-matrix junctions. Phosphorylated Focal 
Adhesion Kinase (pFAK), also known as protein tyrosine kinase 2 (PTK2), 
contributes to cell adhesion and migration. Previous studies from our 
laboratory demonstrated that pFAK and vinculin were both relocated in 
Sca-1+ progenitor cells after a wide range of stimuli. Our results revealed that 
the relocations of cytoskeleton-related proteins such as phosphorylated FAK 
(pFAK) (Figure 3.15) and vinculin (Figure 3.16) were observed 15 minutes 
after the treatment in Sca-1+ progenitor cells, indicating the final stages of cell 
migration. Taken together, these results imply that leptin can induce the 





Figure 3.13. Leptin activated the pSTAT3 and pERK1/2 signaling 
pathways in Sca-1+ adventitial progenitor cells. A and B, The activation of 
pSTAT3 was detected by performing Western blotting on Sca-1+ progenitor 
cells in response to 100 ng/ml of leptin (n=6). C and D, The activation of 
pERK1/2 was detected by performing Western blotting on Sca-1+ progenitor 
cells in response to 100 ng/ml of leptin (n=10). Untreated cells served as a 
control. Images shown are representative of at least 3 independent 





Figure 3.14. Leptin induces the migration of Sca-1+ adventitial 
progenitor cells via the activation of GTPase Cdc42 and Rac1. A and B, 
The quantification of activated GTPase Cdc42 (A) and Rac1 (B) was 
evaluated in response to 100ng/mL leptin by performing G-LISA G-protein 
activation assays (n=3). Untreated cells were served as control. All graphs 







Figure 3.15. Leptin induces the migration of Sca-1+ adventitial 
progenitor cells by activating the relocation of pFAK. A, 
Immunofluorescence was performed on Sca-1+ progenitor cells in response 
to 100 ng/mL of leptin for the detection of pFAK (n=5). Dashed boxes 
represent magnified fields. Red arrows indicate the activated proteins (scale 
bars, 3 µm and 1µm). Untreated cells served as a control. Images shown are 




Figure 3.16. Leptin induces the migration of Sca-1+ adventitial 
progenitor cells by activating the relocation of Vinculin. A, 
Immunofluorescence was performed on Sca-1+ progenitor cells in response 
to 100 ng/mL of leptin for the detection of vinculin (n=5). Dashed boxes 
represent magnified fields. Red arrows indicate the activated proteins (scale 
bars, 3 µm and 1µm). Untreated cells served as a control. Images shown are 











3.7 Involvement of OBR, ERK1/2, and STAT3 in Sca-1+ 
Progenitor Cells. 
So far we proved that OBR, STAT3, ERK1/2, Rho GTPases, pFAK and 
Vinculin were involved in Sca-1+ progenitor cell response to leptin. However, 
their interactions remain unknown. Therefore, we pretreated Sca-1+ 
progenitor cells with different inhibitors, followed by the stimulation of 
100ng/mL of leptin. Western blotting revealed that inhibition of the ERK 
pathway did not affect the activation of pSTAT3 in response to leptin at an 
early stage (Figure 3.18A, B and C). The inhibition of the STAT3 pathway 
markedly decreased the expression of pERK1/2 at an early stage, indicating 
that pERK1/2 is the downstream of pSTAT3 in the OBR-mediated response to 
leptin (Figure 3.18D, E and F). The late activation of pSTAT3 and pERK at 4 
hours (Figure 3.18) after treatment may be caused by the depletion of STAT3 
inhibitor or other unknown signaling pathways. OBR deficiency prevented the 
increase of pSTAT3 with the treatment with 100 ng/mL of leptin, but pERK1/2 
was still activated at the late stage (Figure 3.18G, H and I), indicating that 
other receptors or signaling pathway independent of OBR may be involved in 
leptin-induced cell response.  
So far, OBR was regarded as only functional receptor for leptin. We hence 
performed a qPCR for the expression of cell migration-related receptors such 
as CCR 1, 2, 7, 9 and CXCR 3, 4, 5 as it was shown previously that they were 
upregulated in Sca-1+ progenitor cells during migration (Mei Mei Wong et al., 
2013b). Surprisingly, the expression of CXCR5 gene (Figure 3.19) was 
upregulated 24 hours after the treatment with leptin, indicating its potential 
role in leptin-induced signaling pathways. We also performed MAPK protein 
arrays on leptin-stimulated Sca-1+ progenitors. Various phosphorylated 
MAPK proteins were activated (Figure 3.20) such as p38, CREB, GSK3a, 
MKK3, RSK1 and 2. However, the potential interactions between CXCR5, 
MAPK pathway and leptin need further investigation. Taken together, we 
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confirmed that STAT3 is the upstream of ERK in leptin-induced cell response. 
 
 
Figure 3.17. Leptin activated pMEK1/2 but not pMKK3/6 signaling 
pathways on Sca-1+ adventitial progenitor cells. A, Western blotting was 
performed on Sca-1+ progenitor cells in response to 100 ng/ml leptin for the 
detection of pMKK3/6 (n=3), pMEK1/2 (n=4). B and C, The quantification of 
the activation of pMKK3/6 and pMEK1/2. All graphs are shown as mean ± 
SEM. *p<0.05, **p<0.01, ***p<0.001. 
 
 
Figure 3.18. OBR and STAT3 were the upstream of ERK1/2. A, Western 
blotting was performed on Sca-1+ progenitor cells in response to 100 ng/ml 
leptin with ERK inhibitor for the detection of pSTAT3 (n=8) and pERK1/2 
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(n=10). B and C, The quantification of the activation of pSTAT3 and pERK1/2. 
D, Western blotting was performed on Sca-1+ progenitor cells in response to 
100 ng/ml leptin with STAT3 inhibitor for the detection of pSTAT3 (n=4) and 
pERK1/2 (n=4). E and F, The quantification of the activation of pSTAT3 and 
pERK1/2. G, Western blotting was performed on Lepr-/-Sca-1+ progenitor 
cells in response to 100 ng/ml for the detection of pSTAT3 (n=4) and 
pERK1/2 (n=4). H and I, The quantification of the activation of pSTAT3 and 





Figure 3.19. Leptin could enhance the expression of CXCR5 . Expression 
of CXCR5 for Sca-1+ progenitor cells was evaluated by qPCR 24 hours after 






Figure 3.20. Leptin activated various MAPK pathways on Sca-1+ 
adventitial progenitor cells. A, The expression of MAPK-related protein was 
detected by applying MAPK protein microarrays over time in response to 100 



















3.8 Inhibition of ERK, OBR and STAT3 Could Decrease 
the Cell Migration 
Our results suggested that OBR, STAT3, and ERK1/2 were involved in 
leptin-induced cell response, but whether these signaling pathways were 
involved in cell migration or other cell responses remained unclear. Thus, we 
performed transwell and wound-healing analyses using a Lepr-/- cell model 
and pathway inhibitors. Inhibitors of leptin receptor, STAT3 and ERK1/2 were 
applied in the upper chamber of the transwell, while 100 ng/mL of leptin was 
added into the lower chamber of the transwell. Our results demonstrated that 
after 16-hour incubation, leptin antagonist CYT-354 (Figure 3.21) and STAT3 
inhibitor WP1066 (Figure 3.22) led to a considerable reduction in Sca1+ cell 
migration in transwell assays. Consistent with the results above, inhibition of 
ERK pathway substantially attenuated the cell migration both in 
wound-healing (Figure 3.23) and transwell assays (Figure 3.24), especially at 
a high dose of inhibitors. The migration of Lepr-/- Sca-1+ progenitor cells in 
both wound-healing (Figure 3.25) and transwell assay (Figure 3.26) was 
significantly reduced in response to 100 ng/mL of leptin compared to Lepr+/+ 
cells, suggesting that most of leptin-induced cell migration was mediated by 
leptin receptor b (OBR). In summary, OBR, STAT3 and ERK could participate 





Figure 3.21. Leptin-induced chemotaxis can be abolished by CYT-354 
treatment. A and B, Chemotaxis of Sca-1+ progenitor cells in response to 
100 ng/mL of leptin and CYT-354 (A) (n=5) in an 8.0 µm transwell system was 
identified using 1% crystal violet staining after 16-hour incubation (scale bars, 
20 µm). Serum-free medium and dimethyl sulfoxide (DMSO) were used as 
controls. Migration index of transwell assays was defined as the mean ratio of 
treatment to control of cell numbers counted per 5 random fields at 20X 







Figure 3.22. Leptin-induced chemotaxis can be abolished by WP1066 
treatment. A and B, Chemotaxis of Sca-1+ progenitor cells in response to 
100 ng/mL of leptin and WP1066 (A) (n=5) in an 8.0 µm transwell system was 
identified using 1% crystal violet staining after 16-hour incubation (scale bars, 
20 µm). Serum-free medium and dimethyl sulfoxide (DMSO) were used as 
controls. Migration index of transwell assays was defined as the mean ratio of 
treatment to control of cell numbers counted per 5 random fields at 20X 









Figure 3.23. Inhibition of ERK pathway significantly reduced the 
migration of Sca-1+ adventitial progenitor cells in response to 100ng/mL 
leptin. A and B, Migration of Sca-1+ progenitor cells in response to 100 
ng/mL of leptin and ERK inhibitor was evaluated by applying 1% crystal violet 
staining after 16-hour incubation (scale bars, 50 µm, n=5). Migration index for 
wound healing assays was defined as the mean ratio of treatment to control 
of migrated area analyzed per 5 random fields at 20X magnification. All 







Figure 3.24. Inhibition of ERK pathway significantly reduced the 
chemotaxis of Sca-1+ adventitial progenitor cells in response to 
100ng/mL leptin. A and B, Chemotaxis of Sca-1+ progenitor cells in 
response to 100 ng/mL of leptin and ERK inhibitor was documented by using 
an 8.0 µm transwell system (scale bars, 50 µm, n=5). Serum-free cultured 
medium and dimethyl sulfoxide (DMSO) without leptin treatment was used as 
controls for the migratory assays above. Migration index for transwell assays 
was defined as the mean ratio of treatment to control of cell numbers counted 
per 5 random fields at 20X magnification. All graphs are shown as mean ± 






Figure 3.25. Lack of OBR significantly reduced the migration of Sca-1+ 
adventitial progenitor cells in response to 100ng/mL leptin. A and B, 
Migration of Sca-1+ progenitor cells from db/db mice in response to an 
increasing gradient concentration of leptin was evaluated by 1% crystal violet 
staining after 16-hour incubation (scale bars, 50 µm, n=5). Serum-free 
cultured medium and dimethyl sulfoxide (DMSO) without leptin treatment was 
used as controls for the migratory assays above. Migration index for wound 
healing assays was defined as the mean ratio of treatment to control of 
migrated area analyzed per 5 random fields at 20X magnification. All graphs 





Figure 3.26. Lack of OBR pathway significantly reduced the chemotaxis 
of Sca-1+ adventitial progenitor cells in response to 100ng/mL leptin. A 
and B, Chemotaxis of Sca-1+ progenitor cells from db/db mice in response to 
an increasing gradient of leptin in an 8.0 µm transwell system was identified 
by applying 1% crystal violet staining after 16-hour incubation (scale bars, 50 
µm, n=5). Serum-free cultured medium and dimethyl sulfoxide (DMSO) 
without leptin treatment was used as controls for the migratory assays above. 
Migration index for transwell assays was defined as the mean ratio of 
treatment to control of cell numbers counted per 5 random fields at 20X 











3.9 OBR Is Required for the Migration of Sca-1+ 
Progenitor Cells In Vivo 
We investigated the role of OBR in Sca-1+ cell migration in vivo, following a 
guide-wire injury of the femoral artery in mice. Femoral arteries after 
endovascular injury displayed a very strong autofluorescence at the 
wavelength of 488 nm, which could make it difficult to track the transplanted 
GFP cells. Therefore, Sca-1+ progenitor cells were transfected with lentiviral 
vectors harboring RFP gene to trace live cell migration in vivo (Figure 3.27). 
The RFP Sca-1+ progenitor cells were photographed at the wavelength of 594 
nm. FACS assays demonstrated that 91.2% of Sca-1+ progenitor cells 
successfully expressed RFP (Figure 3.28). Male mice were randomly divided 
into two groups: one group underwent guide-wire injury of femoral artery, 
followed by transplantation of RFP Sca-1+ progenitor cells in 30 µL of Matrigel 
on the adventitial side of the injured vessel. Another group underwent the 
same procedure, but additionally CYT-354 (Leptin antagonist) was mixed with 
the Matrigel. One or three days after surgery, the injured femoral arteries 
were harvested, and En Face staining was performed. Our data 
demonstrated that Sca-1+ progenitor cells could migrate from the adventitia to 
intima at a very early stage (Figure 3.29Aa, Ab, 3.30A, B and C). Three days 
after the endovascular injury, Sca-1+ progenitor cells were discovered in the 
media layer of femoral arteries (Figure 3.31A). When the leptin inhibitor 
CYT-354 was added in Matrigel®, Sca-1+ progenitor cells migration was 
significantly alleviated, indicating the substantial effect of leptin and OBR on 
cell migration in vivo (Figure 3.29Ac, Ad, 3.30A, B, and D). We also 
transplanted Sca-1+ progenitor cells on the femoral arteries of db/db mice. It 
was well known that db/db mice were atherosclerosis protective (Stephenson 
et al., 2003). Surprisingly, the migratory cells were also observed in injured 
arteries three days post-surgery (Figure 3.31B, and 3.28 C) although the 
number of migratory cells was reduced in comparison to what was observed 
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in wild-type mice (Figure 3.32A). 
Additionally, a population of migratory RFP Sca-1+ progenitor cells acquired 
SMC markers (Figure 3.33A) and lost Sca-1 marker expression (Figure 3.33B) 
during the migration. It revealed the possibility that these cells may undergo 
differentiation in vivo before they reach the intima. Therefore, we also 
assessed the change of SM22α and calponin expression in Sca-1+ progenitor 
cells in response to 100 ng/mL of leptin. Our data showed that leptin could 
potentially induce cell differentiation after 24-hour treatment (Figure 3.34). 
However, full mechanisms of cell differentiation needs further investigation. 
 Next, we applied Lepr-/- Sca-1+ progenitor cells on the injured arteries of 
wild-type mice and found that very few RFP+ cells had migrated inside the 
artery (Figure 3.31C, 3.32A), the reason of which may be related to lack of 
leptin-induced cell migration on Lerp-/- Sca-1+ progenitors. These results 
demonstrated that the OBR on Sca-1+ progenitor cells plays a key role in cell 
migration from adventitia to intima after endothelial injury. Indeed, lack of 











Figure 3.27. RFP-Sca-1-APC cells showed red fluorescence in vitro. 
Sca-1+ progenitor cells were successfully transfected by RFP lentivirus (scale 




Figure 3.28. Identification of RFP and non-RFP Sca-1+ adventitia 
progenitor cells after lentivirus transfection. A, Confirmation of the 
existence of RFP in Sca-1+ adventitia progenitor cells with primary antibodies 




Figure 3.29. Sca-1+ progenitor cells could migrate towards intima on 1 
and 3 days post-surgery. A, 1*106 RFP Sca-1+ with (c and d, scale bar, 50 
µm) or without CTY-354 (a and b, scale bar, 100 µm) were seeded in the 
adventitial side of injured femoral arteries (n=6). En face staining showed that 
the RFP cells migrated from the adventitia to the intima on day 1 or 3 




Figure 3.30. Leptin-induced migration of Sca-1+ progenitor cells can be 
abolished by CYT-354 treatment in vivo. A, Quantification of migratory 
cells from the adventitia to intima with or without CYT-354 inhibitor on day 1 
post-surgery. B, Quantification of migratory cells from the adventitia to intima 
with or without CYT-354 inhibitor on day 3 post-surgery. C, Quantification of 
migratory cells from the adventitia to intima without CYT-354 inhibitor on day 
1 or 3 post-surgery. D, Quantification of migratory cells from the adventitia to 
intima with CYT-354 inhibitor on day 1 or 3 post-surgery.Cell migration assay 
in vivo was performed in wild-type mice. All graphs are shown as mean ± 




Figure 3.31. Leptin receptor played an important role in cell migration in 
vivo. A, Cell migration assay in vivo was performed in wild-type mice. 1*106 
RFP Sca-1+ were seeded in the adventitial side of injured femoral artery in 
wild-type mice. En face staining showed that the RFP cells migrated towards 
the intima at 72 hours after the surgery (scale bar, 30 µm, n=6). B, 1*106 RFP 
Sca-1+ were seeded in the adventitial side of injured femoral artery in db/db 
mice. En face staining showed that the RFP cells migrated towards the intima 
at 72 hours after the surgery (scale bar, 100 µm, n=6). C, 1*106 RFP lepr-/- 
Sca-1+ were seeded in the adventitial side of injured femoral artery in 
wild-type mice. En face staining showed that the RFP cells did not migrate 






Figure 3.32. Lack of leptin receptor in Sca-1+ progenitor cells abolished 
the leptin-induced cell migration in vivo. A, Quantification of migratory cells 
from the adventitia for group A, B and C in Figure 3.27. All graphs are shown as mean ± 
SEM. *p<0.05, **p<0.01, ***p<0.001. 
 
 
Figure 3.33. Sca-1+ progenitor cells underwent cell differentiation in vivo. 
A, 1*106 RFP Sca-1+ cells were seeded in the adventitial side of injured 
femoral artery in db/db mice. En face staining showed that the RFP cells 
acquired smooth muscle cell marker (Alexa 488; green) at 72 hours after the 
surgery (scale bar, 20 µm, n=6). B, 1*106 RFP Sca-1+ cells were seeded in 
the adventitial side of injured femoral artery in wild-type mice. En face staining 
showed that some RFP cells lost Sca-1+ marker (Alexa 488; green) at 72 




Figure 3.34. Leptin may induce the differentiation of Sca-1+ progenitor 
cells towards SMC. A, Expression of Calponin (n=5) for Sca-1+ progenitor 
cells was evaluated by qPCR in response to 100 ng/mL leptin. All graphs are 















3.10 Migration of Sca-1+ Progenitor Cells Is Related to 
Elevated Serum Leptin 
Data presented so far indicated that Sca-1+ progenitor cells could migrate into 
the injured artery and the absence of OBR could diminish this effect. However, 
the factor responsible for Sca-1+ progenitor migration into the intima was still 
unknown. As leptin could induce Sca-1+ progenitor cell migration in vitro, we 
wondered whether the concentration of leptin was also enhanced after 
endovascular injury. Therefore, we performed an ELISA to measure serum 
leptin level on day 1, 7 and 14 after the guide-wire injury and assessed 
whether leptin could play a similar role in vivo. Our data revealed that serum 
leptin increased one day post-surgery (Figure 3.35). This upregulation could 
be the inducer of Sca-1+ progenitor cells migration in vivo post-surgery. In 
addition, db/db mice showed a much higher concentration of serum leptin 
(Figure 3.36) which may explain the Sca-1+ cell migration we observed in 
db/db mice (Figure 3.31B).  
Also, we detected a higher immunostaining for leptin in cells of the vessel 
wall (Figure 3.38B) one day post-surgery compared to the immunostaining in 
an uninjured artery (Figure 3.38A). Western blotting for the whole artery 
revealed that expression of leptin was upregulated one day after the 
guide-wire injury (Figure 3.37). Since the expression of leptin seemed to 
originate from smooth muscle cells in medial layer (Figure 3.38B), we also 
performed immunostaining for SMC with leptin primary antibody. We 
confirmed that SMCs could express leptin in vitro under normal culturing 
conditions (Figure 3.39), providing another possible origin of leptin in vivo. 
These data, taken together, demonstrated that the expression of leptin was 





Figure 3.35. Serum leptin was upregulated on 1 day after surgery. Serum 
leptin in wild-type mice on day 1 (n=10), 7 (n=5) and 14 (n=12) after injury 
were quantified by using leptin ELISA kit. All graphs are shown as mean ± 
SEM. *p<0.05, **p<0.01, ***p<0.001. 
 
 
Figure 3.36. Serum leptin was much higher in db/db mice. Serum leptin in 
wild-type and db/db mice was quantified by using leptin ELISA kit. All graphs 




Figure 3.37. The expression of leptin was upregulated after surgery. A, 
Expression of leptin in the injured or non-injured arteries was documented by 
performing western blotting one day post-surgery (n=4). B, Quantification of 
leptin expression in non-injured and injured vessels. All graphs are shown as 





Figure 3.38. The expression of leptin was upregulated in the injured 
artery. A and B, Difference in expression of leptin (Alexa 488; green) in 
non-injured (A) artery (n=6) and injured (B) artery (n=10) was analyzed on 1 
day post-suegery by immunofluorescence (scale bars, 30 and 7 µm). C, 




Figure 3.39. Smooth muscle cells showed expression of leptin in vitro. 
Expression of leptin in smooth muscle cell (Alexa 594; red) in vitro was 


















3.11 Migration of Sca-1+ Progenitor Cells Contribute to 
Neointimal Formation 
We so far confirmed that OBR played an important role in the migration of 
Sca-1+ progenitor cells both in vivo and in vitro, especially in a short-term 
period. To explore the long-term role of Sca-1+ progenitor cells in neointimal 
formation, guide-wire injury was performed in wild-type mice. Male mice were 
randomly separated into two groups: one group underwent guide-wire injury 
only; while another group underwent an additional Sca-1+ cell transplantation 
in 30 µL of Matrigel immediately after the injury. The injured arteries were 
collected either 2 or 4 weeks post-surgery. Histological and morphometric 
analyses, using paraffin sections of injured femoral arteries, were performed. 
Wild-type mice in the injury model developed moderate neointimal formation 
two weeks after the injury, resulting in minor artery narrowing (Figure 3.40 
and 3.41A). Neointimal lesions grew significantly in four weeks post-surgery 
along with a significant reduction in media area (Figure 3.40 and 3.41B to E). 
The intimal layer increased markedly in both area and thickness, resulting in a 
high intima-media ratio four weeks after injury (Figure 3.41D). 
Immunohistochemistry (Figure 3.40B) and immunofluorescence (Figure 
3.40C) for αSMA showed that the main component of neointimal formations 
was smooth muscle cells. Hyperleptinemia has been related to the 
recruitment of leukocytes and macrophages to the endothelial wall at the 
early stage of atherosclerosis(Yamagishi et al., 2001). Immunostaining for 
F4/80 revealed that macrophages started to infiltrate the injured artery from 5 
days post-surgery (Figure 3.42C). Moreover, we observed that F4/80 positive 
cells in the neointima 7 days post-surgery in wild-type mice (Figure 3.42D). 
The data from wild-type mice with guide-wire injury only were used as a 
surgery control for further comparison to other groups with different 
treatments.  
Transplantation of Sca-1+ progenitor cells significantly augmented 
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neointimal formation in wild-type mice 2 weeks post-surgery (Figure 3.44Ad, 
3.45 A to D) in comparison to the mice with injury only (Figure 3.45D). This 
increase in neointimal formation could be abolished when the cells were 
transplanted with 1000 ng/mL of leptin antagonist CYT-354 (Figure 3.44Aa, 
Ac, 3.45 A to C). Van Gieson staining revealed that there was no significant 
difference of the development of fibrosis after the transplantation of 
exogenous Sca-1+ progenitor cells (figure 3.43). In short, transplanted Sca-1+ 
progenitor cells could significantly enhance neointimal formation two weeks 
after surgery, but the administration of CYT-354 inhibited the formation of 
neointima (Figure 3.45D), indicating that leptin and OBR in Sca-1+ progenitor 
cells are crucial during the development of neointimal formation after 





Figure 3.40. Guide-wire injury developed significant neointimal 
formation. A, H&E staining of the femoral artery after guide-wire injury was 
performed (scale bar, 50 and 10 µm, n=10). B and C, The composition of the 
neointima was evaluated by immunohistochemistry (B) and 
immunofluorescence (C) for smooth muscle actin on frozen sections of 
femoral artery at 2 or 4 weeks after surgery (scale bar, 50 and 10 µm, n=10). 
Dashed box represented the magnified field. Arrows indicate SMCs or ECs. 
EC indicates endothelium; SMC, smooth muscle cells; Neo, neointima; M, 
media; SMA, smooth muscle actin; 2W, 2 weeks; 4W, 4 weeks. 
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Figure 3.41. Guide-wire injury induced significant neointimal formation 
4 weeks after surgery. A, Quantification of lumen area of injured arteries 
(n=10). B, Quantification of media area of injured arteries (n=10). C, 
Quantification of neointimal area of injured arteries (n=10). D, Quantification 
of ratio of neointima to media of injured arteries (n=10). E, Quantification of 
ratio of media to adventitia of controls and injured arteries (n=10). Graphs are 
shown as mean ± SEM. *P<0.05, **P<0.01, ***P<0.001. EC indicates 
endothelium; SMC, smooth muscle cells; Neo, neointima; M, media; SMA, 





Figure 3.42. The expression of macrophage marker F4/80 was 
upregulated after surgery around the injured artery. Expression of 
macrophage (Alexa 488; green) in injured artery was analyzed on 1(A, n=10), 
3(B, n=7), 5(C, n=5) and 7(D, n=10) days post-operation by performing 
immunofluorescence. (scale bars, 50 and 10 µm). Dashed box represented 




Figure 3.43. Transplantation of exogenous Sca-1+ progenitor cells did 
not affect the extent of firbosis during the neointimal formation. A, Cross 
sections of injured femoral artery at 1 week post-surgery were analyzed by 
Elastica-van Gieson staining (scale bars, 50 and 10 µm, n=3). B, Lepr+/+ 
Sca-1+ progenitor cells were seeded on the adventitial side of injured artery in 
wild-tpye mice. Cross sections of femoral artery at 1 week post-surgery were 
analyzed by Elastica-van Gieson staining (scale bars, 50 and 10 µm, n=3). C, 
Cross sections of injured femoral artery at 2 week post-surgery were 
analyzed by Elastica-van Gieson staining (scale bars, 50 and 10 µm, n=3). D, 
Lepr+/+ Sca-1+ progenitor cells were seeded on the adventitial side of injured 
artery in wild-tpye mice. Cross sections of femoral artery at 2 week 
post-surgery were analyzed by Elastica-van Gieson staining (scale bars, 50 






Figure 3.44. CYT-354 can significantly inhibit neointimal formation 2 
weeks after endovascular injury. Sca-1+ progenitor cells (1*106) were 
seeded on the adventitia of previously injured vessels and allowed to migrate 
with or without CYT-354 in the Matrigel. A, Paraffin sections of injured femoral 
arteries were observed by performing H&E staining (scale bars, 50 and 10 µm, 
n=6). Dashed boxes represented the magnified field. Neo, neointima; M, 




Figure 3.45. Transplantation of progenitor cells enhanced neointimal 
formation while CYT-354 significantly inhibited 2 weeks after 
endovascular injury. Sca-1+ progenitor cells (1*106) were seeded on the 
adventitia of previously injured vessels and allowed to migrate with or without 
CYT-354 in the Matrigel®. A, Quantification of ratio of neointima to media of 
injured arteries (n=6). B, Quantification of ratio of neointima to adventitia of 
injured arteries (n=6). C, Quantification of ratio of media to adventitia of 
injured arteries (n=6). D, Quantification of ratio of neointima to media of 
injured arteries with or without transplanted cells (n=6). Graphs are shown as 
mean ± SEM. Dashed boxes represented the magnified field. *P<0.05, 





3.12 Wire Injury Induces Neointimal Formation in 
Wild-type But Not in db/db Mice 
We performed guide-wire injury of femoral arteries in db/db mice. The injured 
arteries were collected 2 or 4 weeks after surgery. The size of neointimal 
formation measured in db/db mice was much smaller than wild-type mice two 
weeks after the injury (Figure 3.47A). Of note, they had a higher 
concentration of leptin in the circulation (Figure 3.36), implying that the 
absence of leptin receptor may serve as a protective role in vascular 
remodeling. Previous reports have suggested that the lack of neointimal 
formation in db/db mice was mainly due to the inhibition of smooth muscle 
cells proliferation (Stephenson et al., 2003). We confirmed this conclusion by 
performing BrdU proliferation assays for SMC and Sca-1+ adventitial 
progenitor cells from wild-type or db/db mice. Data showed that the absence 
of OBR could significantly decrease the proliferative abilities of both SMC and 
progenitors (Figure 3.46A and B). Taken together, db/db mice could not 
develop neointimal formation, which was probably caused by reduced ability 















Figure 3.46. SMC from db/db mice showed a difficulty to expand in vitro. 
A, Morphology of Sca-1+ progenitor cells from db/db mice. B, SMC from 
db/db mice had difficulty to proliferate in vitro. C and D, Proliferation between 
Lepr-/- or lepr+/+ Sca-1+ progenitors (C, n=4) and SMC (D, n=4) was examined 
by BrdU assay after 16-hour incubation with 100 ng/mL leptin. Serum-free 
cultured medium without leptin treatment was used as a control for the 
migration assays above. Figures shown above are representative of at least 3 
separate experiments (scale bars, 50 µm). APC indicates Sca-1+ adventitial 
progenitor cells; SMC indicates smooth muscle cells. All graphs are shown as 







3.13 Neointimal Accumulation of Sca-1+ Progenitor 
Cells Is Mediated by Leptin Receptor 
To better understand the specific role of OBR expressed on Sca-1+ progenitor 
cells in neointimal formation, the guide-wire injury mouse model was 
performed in wild-type and db/db mice and followed with transplantation of 
Sca-1+ progenitor cells. Briefly, experiments were performed on two groups of 
animals: one group of wild-type mice underwent guide-wire injury, followed by 
a transplantation of 1*106 Lepr-/- Sca-1+ progenitor cells on the adventitial side 
of injured artery; another group of db/db mice underwent the same procedure 
but received 1*106 Lepr+/+ Sca-1+ progenitor cells. The injured arteries were 
harvested 2 weeks after the surgery.  
Our data revealed that in db/db mice receiving Lepr+/+ Sca-1+, there was a 
significant increase in neointimal formation (Figure 3.47B) compared to the 
group with injury only (Figure 3.47A and 3.48A). Lepr-/- Sca-1+ cells (Figure 
3.47D), on the contrary, could not enhance neointimal lesion in wild-type mice 
compared to the group with injury and the transplantation of Lepr+/+ Sca-1+ 
cells also in wild-type mice (Figure 3.47C and 3.48B). Using the 
immunofluorescent staining for SMCs and ECs markers, we analyzed the 
composition of Sca-1+-induced neointimal formations (Figure 3.47). 
Interestingly, there was a thick layer of CD31+ cells in db/db mice two weeks 
after the vessel injury, which may serve as an example of protective role of 
neointimal formation (Figure 3.47A). Taken together, our data showed that the 








Figure 3.47. Neointimal Effect of Sca-1+ Progenitor Cells Is Mediated by 
Leptin Receptor. A, Cross sections of femoral artery from db/db mice at 2 
weeks after the surgery were analyzed by H&E staining and 
immunofluorescence for αSMA and CD31 (scale bars, 50 and 10 µm, n=6). B, 
Lepr+/+ Sca-1+ progenitor cells were seeded on the adventitial side of injured 
artery in db/db mice. Cross sections of femoral artery from db/db mice at 2 
weeks after the surgery were analyzed by H&E staining and 
immunofluorescence for αSMA and CD31 (scale bars, 50 and 10 µm, n=5). C, 
Lepr+/+ Sca-1+ progenitor cells were seeded on the adventitial side of injured 
artery in wild-type mice. Cross sections of femoral artery from wild-type mice 
at 2 weeks after the surgery were analyzed by H&E staining and 
immunofluorescence for αSMA and CD31 (scale bars, 50 and 10 µm, n=8). D, 
Lepr-/- Sca-1+ progenitor cells were seeded on the adventitial side of injured 
164 
 
artery in wild-type mice. Cross sections of femoral artery from db/db mice at 2 
weeks after the surgery were analyzed by H&E staining and 
immunofluorescence for αSMA and CD31 (scale bars, 50 and 10 µm, n=6). 
Dashed box represented the magnified field. Arrows indicated the SMC and 
EC respectively. EC indicates endothelium; SMC, smooth muscle cells; Neo, 
neointima; M, media; SMA, smooth muscle actin; 2W, 2 weeks; 4W, 4 weeks. 
APC: adventitial progenitor cells. 
 
 
Figure 3.48. Leptin Receptor deficient APC could not induce neointimal 
formation 2 weeks post-surgery. A, Quantification of the ratio of media to 
adventitia of injured arteries for group A and B in figure 3.42. B, Quantification 
of the ratio of media to adventitia of injured arteries for group C and D in figure 







3.14 Neointima in Db/Db Mice Partly Originated From 
Exogenous Sca-1+ Progenitors 
When Lepr+/+ Sca-1+ progenitors were transplanted to db/db mice, an 
apparent formation of neointima could be detected. Since db/db arteries were 
unable to develop any neointimal lesions following guide-wire injury only, the 
origin of neointima in the db/db mice following cell transplantation was of 
interest. Db/db mice do not express OBR in any cell types. Immunostaining 
did not show any positive expression of OBR in the femoral artery (Figure 
3.9C). When Lepr+/+ Sca-1+ cells were applied in db/db mice, this group of 
cells became the only origin of Lepr positive cells or tissues. Therefore, we 
performed immunostaining with OBR primary antibody in db/db mice which 
received exogenous Lepr+/+ progenitor cells. Immunostaining of OBR 
revealed a significant number of Lepr+ cells in the neointima, indicating that 
they originated from transplanted Lepr+/+ Sca-1+ progenitor cells (Figure 
3.49A). It is worth noting that not all neointimal cells were OBR positive and 
most of the OBR positive cells did not co-express smooth muscle cell marker. 
Since db/db mice could not develop any neointimal formation after vessel 
injury, the origins of OBR negative cells and the roles of OBR positive cells in 
neointima in db/db mice will need further investigation. On the other hand, 
when Lepr-/- Sca-1+ cells were applied in wild-type mice, immunostaining 
revealed that OBR expressed in all three layers, which was considered as an 
intrinsic expression in wild-type mice, and neointima could not be increased 
(Figure 3.49B). In order to elucidate whether hematopoietic cells could 
contribute to the neoinitmal formation, we performed the immunostaining with 
CD45 as a hematopoietic marker and OBR represented as exogenous Sca-1+ 
progenitor cells primary antibody in db/db mice (Figure 3.50). Our data 
demonstrated that both adventitial and hematopoietic progenitor cells could 





Figure 3.49. Neointima was originated from Lepr+ Sca-1+ Progenitor 
Cells. A, Lepr+/+ Sca-1+ progenitor cells were seeded on the adventitial side 
of injured artery in db/db mice. Cross sections of femoral artery from db/db 
mice at 2 weeks after the surgery were analyzed by immunofluorescence for 
αSMA and OBR (scale bars, 50 and 10 µm, n=5). B, Lepr-/- Sca-1+ progenitor 
cells were seeded on the adventitial side of injured artery in wild-type mice. 
Cross sections of femoral artery from wild-type mice at 2 weeks after the 
surgery were analyzed by immunofluorescence for αSMA and OBR (scale 





Figure 3.50. Both adventitial Sca-1+ cells and hematopoietic cells 
contribute to neointimal formation. A, Lepr+/+ Sca-1+ progenitor cells were 
seeded on the adventitial side of injured artery in db/db mice. Cross sections 
of femoral artery from db/db mice at 2 weeks after the surgery were analyzed 
by immunofluorescence for CD45 and OBR (scale bars, 50 and 10µm, n=4). 
Dashed box represented the magnified field. Images shown are 










































Obesity is related to cardiovascular disease, but the underlying mechanisms 
behind obesity-induced cardiovascular disease are not elucidated. Plasma 
leptin, as an adipocyte product, is proposed to be a biological predictor of 
cardiovascular disease (Chu et al., 2001). The focus of atherosclerosis is 
traditionally on endothelium which is the innermost layer of vessels. The 
deeper layers including media, adventitia and perivascular adipose tissue, 
which were proved to be crucial for vascular remodeling, received far less 
attention. Accumulating evidence indicates the presence of vascular 
progenitor cells in all three layers of large and medium-sized blood vessels, 
and these progenitors may participate in vascular remodeling (Cho et al., 
2013; Naito, Kidoya, Sakimoto, Wakabayashi, & Takakura, 2012; Patel et al., 
2017; Z. Tang et al., 2012; Worsdorfer et al., 2017). Recent studies linked 
adipokines and vascular smooth muscle cells. Heart and vascular smooth 
muscle cells are capable of secreting leptin (Hou & Luo, 2011), which can 
subsequently enhance coronary vasoconstriction and smooth muscle 
proliferation via the Rho kinase pathway (Noblet, Goodwill, Sassoon, Kiel, & 
Tune, 2016). What is more, the hypothalamus resistance to leptin did not 
affect the heart and vascular walls (Martin, Qasim, & Reilly, 2008). All these 
findings revealed a possible connection between adipokines, vascular 
progenitor cells and cardiovascular system. However, the relationship 
between adventitial progenitor cells and adipokines remained until now 
unknown. 
In the present study, we have identified the missing link between leptin and 
the resident stem cells in vascular remodeling. We demonstrated that leptin 
was a chemokine for stem/progenitor cell migration and mediated neointimal 
formation in damaged vessels, which can be abrogated by inhibition or 
knockout of the leptin receptor. Modulation of the signaling pathways 
involving OBR-STAT3-Rac/Cdc42-FAK influences cell motility in vitro and 
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vascular remodeling in vessel-injury models. More importantly, for the first 
time, we have successfully shown significant neointimal formation in db/db 
mice, confirming the crucial roles of leptin receptor b (OBRb) and Sca-1+ 
progenitors in vascular remodeling. Thus, our findings provide a novel insight 
into the interaction between leptin and vascular resident progenitor cells in 


























4.1 Characterization of Sca-1+ Progenitor Cells 
Mature arteries are mainly composed of by two cell types, smooth muscle 
cells and endothelial cells (Xiong, 2008). It is well known that both endothelial 
cells and smooth muscle cells can contribute to the development of 
atherosclerosis. The proliferation of smooth muscle cells in the neointima is 
considered as the leading cause of atherosclerosis but their origin is still 
under debate. It was initially believed that smooth muscle cells come from the 
media in response to the chemokines such as PDGF and TGF-β released by 
endothelial cells or aggregated platelets (Russell Ross, Glomset, & Harker, 
1977). However, increasing evidences suggested that vascular progenitor 
cells from adventitia can contribute to atherosclerosis as well.  
Far less attention has been paid to the adventitia of vessel wall. The 
adventitia used to be only regarded as the outermost connective layer of the 
artery but recent studies revealed more roles of the adventitia in vascular 
remodeling. The adventitial layer contains heterogeneous groups of cells. 
Besides resident macrophages, mast cells, T cells, B cells, and dendritic cells 
were also discovered in the adventitia (Galkina et al., 2006; Mäyränpää et al., 
2009; J. Zhou et al., 2010). Also, adventitia is proved to contain progenitor 
cells which can participate in atherosclerosis and other pathological 
processes (Campagnolo et al., 2010; Hoshino et al., 2008; Passman et al., 
2008). Vascular adventitial progenitor cells can differentiate into either 
endothelial cells or smooth muscle cells in certain circumstance. For instance, 
CD34+ vascular progenitor cells derived from embryonic stem cells could 
differentiate into CD31, VE-cadherin positive endothelial cells under VEGF 
stimulation and sm22α, or calponin positive smooth muscle cells under 
PDGF-β stimulation (Ferreira et al., 2007). Sca-1+ cells are non-bone marrow 
derived vascular progenitor cells, found abundantly in vessel walls and 
subsequently cultured in stem cell medium which were also capable of 
differentiating into endothelial cells, smooth muscle cells and cardiomyocytes 
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(Czechanski et al., 2014; Y. Hu et al., 2004; Qingzhong Xiao, Zeng, Zhang, 
Hu, & Xu, 2007). Using an animal model of vein graft, Hu et al. proved that 
about 60% of the smooth muscle cells were from the donor’s vessel wall, and 
about 40% of the smooth muscle cells were from the recipient, possibly from 
blood (Y. Hu et al., 2002). In another experiment, Sca-1+ progenitor cells 
carrying LacZ reporter gene were isolated from the aortic root of apoE-/- mice. 
The vena cava was transplanted into the carotid artery of the recipient mice, 
while the donor Sca-1+ Lac+ cells were applied on the adventitial side of the 
carotid artery. Once atherosclerotic lesions formed, LacZ-smooth muscle 
cells were observed in the grafts, suggesting the migration and differentiation 
of the Sca-1+ progenitor cell from adventitia (Y. Hu et al., 2004).  
Besides, vessels, Sca-1+ progenitor cells also exist in other tissues, such 
as bone marrow and heart, and they have different roles from region to region. 
Sca-1+ was reported as a marker on hematopoietic progenitor cells, in 
combination with c-kit. Also, Sca-1+ markers were identified in the resident 
fibroblast of skin (Driskell et al., 2013), lung (Akamatsu et al., 2013), which 
could differentiate into hypodermal lineage and myofibroblasts respectively. 
Resident cardiac progenitor cells are a promising treatment for myocardial 
infarction. Heart derived Sca-1+ progenitor cells showed the characteristics of 
cardiac progenitor cells, demonstrating multipotent differentiation into cardiac 
cell lineages (H. Wang et al., 2014). 
In this study, we isolated Sca-1+ progenitor cells from the aortic of apoE-/- 
(Lepr+/+) mice and db/db (Lepr-/-) mice. This group of cells physically located 
in the adventitial of big vessels and will undergo a series of cell activities 
under pathological conditions. Application of Sca-1+ progenitor cells to the 
wire-injured femoral artery allowed us to create a reasonable representation 
of vascular dysfunction in a relatively short time. Mice were chosen for animal 
surgery because of its fast breeding and easy access to gene deficient 
models compared to other big animals such as rabbits and rats. By 
performing such experiments, we believed that our findings will be instructive 
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for future studies in vascular remodeling.  
 
4.2 Leptin, OBR and Sca-1+ Progenitor Cells 
Obesity strongly correlated with higher concentration of serum leptin 
associated with higher incidence of cardiovascular diseases. Leptin is a 16 
kDa peptide hormone mainly secreted by white adipose tissue. Leptin, which 
was firstly discovered in 1994, was initially considered as a regulator of 
metabolism. However, accumulating evidence revealed that leptin also played 
an important role in cardiovascular system.  
Schafer et al. confirmed that wild-type mice would have 9-fold higher leptin 
levels in the circulation with high fat diet. The lesions of neointima in carotid 
artery were also strongly enhanced in mice with high-fat diet. Moreover, leptin 
deficient (ob/ob) mice could not develop neointimal formation spontaneously, 
but the neointimal formation in ob/ob mice could be developed with the 
treatment of exogenous leptin (Schäfer et al., 2004). Leptin could induce the 
proliferation and migration of vascular smooth muscle cells and neointimal 
formation, the phenomenon of which could be suppressed genistein (Y. C. 
Tsai et al., 2017). In addition, leptin regulated the osteoblastic differentiation 
of vascular smooth muscle cells by increasing the expression of RANKL (Liu 
et al., 2014). A growing body of evidence showed the effects of leptin on 
vascular smooth muscle cells, endothelial cells and progenitor cells. However, 
little attention has been drawn to adventitial progenitor cells. 
Obesity leads to changes in the levels of plasma adipokines such as 
adiponectin, leptin, visfatin, and resistin, all of which may influence 
cardiovascular system. To determine whether Sca-1+ progenitors could 
response to these adipokines, migratory assays including transwell (Figure 
3.1A) and wound-healing (Figure 3.1B) in response to different adipokines 
were performed. We confirmed that only resistin and leptin could induce the 
migration of Sca-1+ progenitor cells. On the contrary, adiponectin inhibited the 
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migration of Sca-1+ progenitor cells. Since the migration of Sca-1+ could 
enhance the neointimal formation in previous study, we inferred that leptin 
and resistin could probably play a role in vascular remodeling. It is clear that 
OBRb is considered to be the functional receptor which mediates most of the 
biological leptin-induced effects (Yang & Barouch, 2007). However, the 
receptors of resistin were still under debate. OBR is expressed in multiple cell 
types (Koh, Park, & Quon, 2008). Single cell transcriptome analysis from 
previous work in our lab demonstrated that Sca-1+ progenitor cells express 
long-form leptin receptor (data not shown, in press), followed by confirmation 
with Western blotting and immunostaining experiments (Figure 3.6, 3.7 and 
3.9). Therefore, we chose leptin as our main focus in this project, exploring 
the relationship between leptin, Sca-1+ progenitor cells and neointimal 
formation.  
 
4.3 Db/Db Mice, Type II Diabetic Model and Vascular 
Injury 
Db/db mice are greatly applied as a type II diabetes model. Db/db mice fed a 
Western diet shows a similar characteristics to that in type II diabetes 
mellitus(DM) patients, with higher expression of low-density lipoprotein (LDL) 
and cholesterol (Kobayashi et al., 2000), both of which can enhance the 
neointimal formation. Diabetic  
Dyslipidemia greatly contributes to the accelerated atherosclerosis in 
Diabetic mellitus. In previous study, guide-wire injury mouse model was 
performed in both type I and II diabetes mellitus mouse models, creating 
neointima which could be accelerated by arterial injury. In rodent model of 
type I diabetes, neointimal size was not altered after the induction of 
guide-wire injury of femoral artery in ins2akita mice and Sprague-Dawley rat 
treated with streptozotocin (Park et al., 2001). Surprisingly, in db/db mice, 
neointimal formation was greatly reduced even with the help of upregulation 
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of serum leptin, cholesterol and LDL. Leptin can increase sympathetic nerve 
activity and arterial blood pressure (Aizawa-Abe et al., 2000). Arterial rings 
harvested from ob/ob and db/db mice could response to norepinephrine and 
diminish relaxation to acetylcholine, enhancing contractile activity. However, 
increased mechanical force of injured artery did not explain the diminished 
neointima in db/db mice after vessel injury (Winters et al., 2000). 
TUNEL-positive staining 4 hours post-surgery and Ki67 staining 2 weeks 
post-surgery was unchanged compared to Lepr+/+ mice. Therefore, apoptosis 
or proliferation of smooth muscle cells in the medial layer of db/db mice did 
not account for the paradoxical reduction of neointimal formation 
(Stephenson et al., 2003). Since leptin has a wide range of effects on 
vascular cells including platelet and VSMC, it is difficult to figure out the 
paradox without additional specific mutant mouse model. In summary, this 
paradoxical effect demonstrates a potential role of leptin receptor b in 
vascular remodeling as a protective role.  
 
4.4 Leptin Induce Sca-1+ Progenitor Cells via OBR 
Adventitial progenitor cells from aortic adventitia could contribute to 
neointimal formation. These cells express progenitor cell markers, such as 
Sca-1, CD34 and CD117, and are localized in neointima (T.-N. Tsai et al., 
2012) and adventitia (Ergün, Tilki, & Klein, 2011). Several studies has 
revealed that the migration of Sca-1+ progenitor cells can be induced by a 
wide range of stimuli, such as Sirolimus (Mei Mei Wong et al., 2013a), and 
participate in atherosclerosis. Since the expression of leptin receptor b (OBR) 
in Sca-1+ progenitor cells was confirmed as mentioned previously, we 
wondered whether leptin could induce the migration of Sca-1+ progenitor cells 
via OBR.  
We firstly isolated the Sca-1+ adventitial progenitor cells from both wild-type 
and db/db mice. To investigate whether the absence of OBR would affect the 
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phenotype or distribution of Sca-1+ progenitor cells in vitro and in vivo, we 
performed a series of immunostaining for both cells and tissue. Our data 
revealed that there was no any expression of OBR in db/db mice, and the 
distribution of Sca-1+ progenitor cells was not changed in comparison to the 
distribution in wild-type mice (Figure 3.9 B and C). FACS results suggested 
that Sca-1+ progenitor cells expressed CD29, CD34 but not CD45. The 
absence of OBR did not change the phenotype of Sca-1+ progenitors. In 
summary, the expression of OBR is independent with the expression of Sca-1 
and other progenitor markers.  
Migratory assays including transwell and wound healing assays were 
performed. Cell migration could be significantly enhanced in response to 100 
ng/mL of leptin in both transwell assay and wound healing assay. The 
leptin-induced migration could be abolished in response to Leptin antagonists 
which competitively bound to OBR. Leptin antagonist triple mutant mouse 
recombinant used in this project is a single non-glycosilated polypeptide chain, 
with alanine mutagenesis of three amino acids (L39A/D40A/F41A), resulting 
in potent antagonistic activity. In addition, applying Lepr-/- Sca-1+ progenitor 
cells in both transwell and wound-healing assays demonstrated a reduced 
migration. Treatment with different concentrations of leptin in Lepr-/- Sca-1+ 
progenitor cells did not show any difference regarding the cell migration. 
Above data suggested that leptin induced the migration of Sca-1+ progenitor 
cells via OBR. 
 
4.5 The Underlying Mechanism of Leptin-Induce Cell 
Migration of Sca-1+ Progenitor Cells 
Leptin receptor codes for six leptin receptor isoforms via RNA splicing. All of 
them have an extracellular domain which can bind to leptin but only leptin 
receptor b (OBR) contains a full-length intracellular domain which is 
necessary for signal transduction cascade (Friedman & Halaas, 1998). The 
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action of OBR is commonly induced by JAK/STAT (Zabeau et al., 2003), 
AMPK (Minokoshi et al., 2002), PI3-Akt and MAPK (Frühbeck, 2006) 
pathways.  
Consistent with previous studies, leptin could induce the activation of 
phosphorylated STAT3, MEK1/2, and ERK1/2 at an early stage. Either 
inhibition of OBR, STAT3 or ERK1/2 led to a reduction in cell migration in vitro. 
However, a late activation of pERK at 30 minutes after the treatment in Lepr-/- 
cells indicated that other signaling pathways independent of OBR may also 
be involved. We hence performed a qPCR for the expression of cell 
migration-related receptors such as CCR 1, 2, 7, 9 and CXCR 3, 4, 5 as it was 
shown previously that they were upregulated in Sca-1+ progenitor cells during 
migration (Mei Mei Wong et al., 2013b). Surprisingly, the expression of 
CXCR5 gene (Figure 3.19) was upregulated 24 hours after the treatment of 
leptin, indicating its potential role in leptin-induced signaling pathways. 
Previous study demonstrated that the activation of STAT3 in follicular helper T 
(TFH) cells could directly induce the expression of CXCR5 (Tripathi et al., 
2017). Also, Overexpression of CXCR5 in mesenchymal stem cells increased 
their abilities to respond to migratory stimuli and immunomodulatory effects in 
vivo (X. Zhang et al., 2017). However, whether the activation of STAT3 in 
Sca-1+ progenitor cells could enhance the expression of CXCR5 cannot be 
concluded. We also performed MAPK protein arrays on leptin-stimulated 
Sca-1+ progenitors. Various phosphorylated MAPK proteins were activated 
(Figure 3.20). CXCR5 has never been reported as a receptor of leptin. 
Nevertheless other MAPK proteins were related to leptin-induced signaling 
pathway. Thus, an interaction between CXCR5, MAPK pathway and leptin 
still needs further investigation. The Rho GTPase family including Rac1, 
Cdc42, and RhoA is known to regulate the formation of lamellipodia, filopodia 
and focal adhesions (Nobes & Hall, 1999). In our study, Rac1 and Cdc42, 
commonly considered to act upstream of MAPK pathways, were activated by 
100 ng/mL of leptin, followed by an enhanced rearrangement of 
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cytoskeleton-related proteins such as phosphorylated FAK and vinculin.  
Vinculin and FAK are believed to have a close relationship with cell 
migration. Previous work from our laboratory proved that vinculin and FAK 
can be activated in Sca-1+ progenitor cells by a wide range of stimuli, 
eventually leading to cell migration (Yu et al., 2016). However, the influence of 
leptin on vinculin and FAK in Sca-1+ progenitor cells was so far unclear. Our 
new data showed that leptin potently greatly induced vinculin and FAK 
activation in 30 minutes in stem/progenitor cells, and it strongly correlated 
with the phosphorylation of STAT3-GTPase-ERK pathway. Taken together, 
we provided robust data to identify OBR-STAT3- Rac1/Cdc42-ERK-FAK as 
most probable signaling pathway involved in Sca-1+ progenitor cell migration 
in response to leptin, implicating new potential therapeutic targets for vascular 
disease. Schematic figure for leptin-induced signaling pathway in Sca-1+ 





Figure 4.1. Schematic illustration of the roles of exogenous leptin in 
enhancing Sca-1+ adventitial progenitor cells chemotaxis. Elevated leptin 
in circulation or femoral artery after guide-wire injury binds to its receptors 
leptin receptor b on the Sca-1+ adventitial progenitor cells. The GTPases 
Rac1 and Cdc42 are activated leading to the phosphorylation of pERK. Leptin 
also induces the activation of STAT3 pathway and the expression of 
cytoskeleton related proteins paxillin, vinculin and phosphorylated FAK, which 









4.6 Guide-Wire Injury Enhanced the Expression of 
Leptin Locally and Systematically, Inducing Sca-1+ 
Progenitor Cells Migration. 
Atherosclerosis is a chronic cardiovascular disease which can be 
asymptomatic for decades. It is also the leading cause of stroke, myocardial 
infarctions and other vascular diseases of which mechanism is still not fully 
understood. Various animal models are hence developed (Getz & Reardon, 
2012). In the present study, we used guide-wire injury mouse model due to its 
accessible manipulation and relatively quick outcome. 
First applied by Roque et al. in 2000, guide-wire injury model soon became 
widely accepted as it closely resembled the injury of the endothelium and 
vessel wall. Guide-wire injury to the vessel can be achieved by 3 passages of 
a 0.25mm diameter angioplasty guide wire. One hour after the injury, the 
denuded surface was covered with platelets and leukocytes due to the 
accumulation of P-selectin, intercellular adhesion molecule-1 and vascular 
cell adhesion molecular-1 within the injured area. One week post-surgery, 
macrophages and platelets were observed in the vessel wall. Two or four 
weeks post-surgery, guide-wire injury induced a significant neointimal 
hyperplasia along with the rapid accumulation of leukocytes and adhesion 
molecules on the regenerated endothelium (Roque et al., 2000).  
After the endovascular injury, an inflammatory response take place in the 
vessel wall, with the release of chemokines secreted by smooth muscle cells 
and mononuclear cells (Tedgui & Mallat, 2006). However, whether the 
expression of leptin was affected was so far unknown. We demonstrated that 
the levels of leptin in both serum and vessel wall were upregulated one day 
post-surgery. Since higher concentration of leptin could induce the cell 
migration in vitro, we believed that the upregulation of leptin in vivo could also 
induce the migration of Sca-1+ progenitor cells from the adventitia to the 
intima. Although leptin was reported to be mainly released by white adipose 
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tissue (Trayhurn & Beattie, 2001), our immunostaining showed that smooth 
muscle cells could also express leptin both in vivo and in vitro, providing a 
new possibility of additional origin of leptin after the endothelial injury.  
Using a RFP labelling/tracing technique, migratory Sca-1+ cells could be 
traced inside the vessel media layer. Lepr-/- cells or Lepr+/+ treated with 
CYT-354 lost their migratory abilities both in vitro and in vivo. However, when 
Lepr+/+Sca-1+ progenitor cells were transplanted on injured arteries of db/db 
mice which although had a much higher concentration of serum leptin, the 
migration of the progenitor cells was not significantly altered. On the other 
hand, Lack of OBR in db/db mice did not affect the migration of Lepr+/+ Sca-1+ 
progenitor cells. Therefore, progenitor cell migration in vivo is largely 
dependent on the existence of leptin receptors on the cell surface. Moreover, 
Lepr+/+Sca-1+ progenitor cells could acquire smooth muscle cell markers in 
vivo 3 days post-surgery. Quantitative RT-PCR in Sca-1+ cells showed an 
upregulation of SMC markers in response to 100 ng/mL of leptin for 24 hours, 
suggesting that leptin may have a potential role in the differentiation of the 
progenitors towards the SMC fate in vivo (Figure 3.33). Further investigation 
will be needed to confirm a link between leptin and Sca-1+ progenitor cells’ 
differentiation. 
 
4.7 Leptin Induced Neointimal Formation, Which Was 
Originated From Sca-1+ Progenitor Cells. 
The origin of the proliferative SMCs accumulating during neointimal formation 
is still under debate. Fibroblasts (Sartore et al., 2001), smooth muscle cells 
and adventitial progenitor cells (Torsney, Hu, & Xu, 2005) are all believed to 
participate in neointimal formation. In this context, leptin has been reported so 
far to promote integrin-mediated adhesion, recruiting endothelial progenitor 
cells into neointima after vessel injury (Schroeter et al., 2008). Db/db mice 
displayed phenotype of obesity, higher systemic arterial blood pressure, 
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depressed heart rates, hyperlipidemia, severe hyperglycemia, 
hyperinsulinemia and pancreatic dysfunction (da Costa Goncalves et al., 
2009; B. Wang, Charukeshi Chandrasekera, & J Pippin, 2014), all of which 
could contribute to vascular remodeling.  
At first, we confirmed that db/db mice had a higher serum leptin. 
Surprisingly, no neointimal formation could be observed in db/db mice at 2 or 
4 weeks post-operation of guide-wire injury. Besides, there was a thick layer 
of CD31+ endothelial cells in the intima at 2 weeks post-surgery. Furthermore, 
application of Lepr+/+Sca-1+ progenitors on the adventitial side of the injured 
artery in db/db mice resulted in marked neointimal formation 2 weeks 
post-surgery. Previous reports have suggested that the lack of neointimal 
formation in db/db mice was mainly due to the inhibition of proliferation of 
smooth muscle cells (Stephenson et al., 2003). We confirmed this conclusion 
by performing BrdU proliferation assays for SMC and progenitor cells with or 
without OBR. Our data showed that the absence of OBR could significantly 
decrease the proliferative abilities of both SMC and progenitors (Figure 3.46), 
but stimulation with leptin does not influence the proliferation of wild-type cells 
(Figure 3.5). 
 Importantly, we also demonstrated that the inhibition of migration of 
Sca-1+ progenitor cells is of great importance for neointimal formation. 
Without the participation of Lepr-/- smooth muscle cells or other circulating 
Lepr-/- progenitors in db/db mice, a significant neointimal formation was also 
detected 2 weeks post-surgery in db/db mice, solely caused by the 
transplantation of exogenous Sca-1+ progenitor cells.  
Due to the fluorescence quenching of RFP cells or loss of RFP marker after 
cell migration and differentiation in vivo, we are unable to track the cells in 
vivo two weeks post-surgery. Instead, we stained the cross section of db/db 
mice with OBR primary antibody which underwent the transplantation of 
lepr+/+ Sca-1+ cells. Surprisingly, many neointimal cells were OBR positive, 
proving that they originated from the transplanted Sca-1+ progenitors. Since 
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OBR+ cells only represented less than 20% of the neointimal cells, most of 
which did not co-express SMC marker, the origin of the remaining cells is 
unknown and needs further investigation. In addition, whether exogenous 
Lepr+/+ progenitor cells could influence the biological feature of Lepr-/- cells in 
db/db remained unclear. On the contrary, wild-type mice which received 
Lepr-/- Sca-1+ cells only showed few OBR+ cells and smaller neointima. A 
progenitor specific knock out of OBR could be a therapeutic approach for 
vascular disease in the future. Due to technical limitations, we are not able to 
track all RFP Sca-1+ progenitors in vivo in a long-term experiment. A future 
study using Cre-controlled cell linear tracing techniques will be needed for 
long-term tracing experiments and study the differentiation of the prognitors. 
 
4.8 Future Work 
4.8.1 The Role of Leptin in Sca-1+ Progenitor Cells 
Differentiation. 
In the present study, we demonstrated that leptin could induce Sca-1+ 
progenitor cells migration both in vivo and in vivo, enhancing the neointimal 
formation in wire-injured femoral arteries. Previous studies revealed that 
Sca-1+ progenitor cells could differentiate into smooth muscle cells during the 
vascular remodeling (Y. Hu et al., 2004). In addition, leptin promoted the 
osteoblastic differentiation towards smooth muscle cells (Liu et al., 2014). 
Therefore, we assessed whether leptin could induce the differentiation of 
Sca-1+ progenitor cells. Our preliminary results obtained in vitro with qPCR 
and in vivo with immunostaining suggested that Sca-1+ progenitor cells could 
acquire smooth muscle cells marker in response to high concentration of 
leptin. In this case, it would be of great interest to further explore the role of 




4.8.2 Potential Interaction between Leptin and 
OBR-Independent Signaling Pathways. 
We proved that OBR played a substantial role in Sca-1+ progenitor cells 
migration. Lack or inhibition of OBR significantly abolished the cell migration 
both in vivo and in vitro. However, Western blotting revealed that there was a 
late ERK activation even in cells treated with STAT3 inhibitors or using Lepr-/- 
Sca-1+ progenitor cells, suggesting that other OBR-independent signaling 
pathways might have been involved. QPCR of CXCR5 showed a marked 
increase in response to 100 ng/mL of leptin. Besides the activation of ERK1/2 
and MEK1/2, MAPK array demonstrated that various MAPK signaling 
pathways were activated in response to 100 ng/mL of leptin at a very short 
period. Altogether, our data indicated that OBR-STAT3-ERK1/2 was the not 
only pathway, which could be activated by leptin. However, whether other 
receptors and signaling pathways are related to leptin-induced cell migration 
remains unknown. The inhibitor of such signaling pathways and receptor 
should be applied for the further investigation in the future experiments. 
Transcriptome analysis and CHIP assays for Sca-1+ progenitor cells with or 
without leptin treatment could be performed for the selection of the most 
probable receptors and pathways that contribute to the effect which we 
observed. So far OBR was the only reported receptor for leptin, a novel 
receptor for leptin could be of great interest for the studies in the 
cardiovascular and metabolic research field. 
 
4.8.3 Sca-1+ Progenitor Cells Contribute to Vascular 
Remodeling. 
Present study displayed that Sca-1+ progenitor cells could migrate into intima 
3 days post-surgery. However, this in vivo migratory model was achieved by 
the transplantation of large quantity of Sca-1+ progenitor cells in Matrigel 
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outside the vessel wall. Autologous Sca-1+ progenitor cells in wild-type mice 
could be detected using immunostaining for large vessels. However, upon 
injury, they are difficult to track due to limited numbers and loss of Sca-1 
antigen. Thanks to the development of CreERT-technology, the 
Sca-1-Cre-RFP mice would allow us to study not only the migration of Sca-1+ 
cells but also the destiny of the cells that originated from them. In this case, 
we would be able to trace the autologous Sca-1+ progenitor cells for a 
relatively long time. Although we stained OBR in db/db mice as an alternative 
approach to trace the Lepr+/+Sca-1+ progenitor cells, after all it is not the direct 
evidence. Once the Sca-1-CreERT-RFP model is created, various 
experiments can be designed and proceeded subsequently, exploring both 
the differentiation and migration of Sca-1+ progenitor cells in vivo. 
 
4.8.4 The Relationship Between Adipokine, Adipose Tissue, 
Adipose Tissue Derived Stem Cell (ADSC) and Vascular 
remodeling 
Adipose tissue, expanding during obesity, strongly correlated with 
cardiovascular diseases. Perivascular adipose tissue, the adipose 
surrounding the large vessels as a part of adventitia, was found to be a 
potentially cardiovascular risk which contributed to neointimal hyperplasia in 
humans (Manka et al., 2014; Tian et al., 2013). A new consensus is emerging 
that perivascular adipose tissue is associated with cardiovascular disease but 
direct proof is still lacking. In the present study, we demonstrated that leptin 
could induce the Sca-1+ progenitor cells migration, which further enhanced 
neointimal formation. We also discovered that serum leptin was greatly 
upregulated one day post-surgery. However, the origin of leptin remained 
unknown. Adipokines including leptin could be released by adipose tissue, 
but the interaction between leptin, adipose tissue and neointimal formation 
remains unclear. Several studies have already examined the impact of 
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transplanted adipose tissue on local vasculature. In one study, endogenous 
adipose tissue was removed and replaced by either subcutaneous or visceral 
adipose tissue, followed by a guide-wire femoral artery injury (Takaoka et al., 
2009). Subcutaneous fat from normal diet mice could inhibit neointimal 
formation but subcutaneous fat from high-fat diet fed mice had no such effect. 
In addition, visceral epididymal adipose tissue also showed diminished 
neointimal hyperplasia (Takaoka et al., 2009). However, in another article, 
atherosclerosis was quantified after transplantation of visceral or 
subcutaneous fat to the carotid artery and researchers found visceral 
epididymal adipose tissue could augment atherosclerosis whereas 
subcutaneous adipose tissue served as a protective role (Öhman et al., 2011). 
Above contradictive results from different groups suggested the complex 
roles of adipose tissue in vascular remodeling.   
Adipose derived stem cells, or ADSCs, are a population of pluripotent cells 
which are located in adipose tissue (Zuk et al., 2002) and can differentiate 
into various cell lineages, such as adipocytes, osteocytes and neurons, etc 
(Gimble, Katz, & Bunnell, 2007). Several articles addressed its new roles in 
vascular remodeling (Y. J. Kim et al., 2007; Suzuki, Fujita, Takahashi, Oba, & 
Nishimatsu, 2015). We next plan to perform a series of animal models related 
to the transplantation of ADSC or adipose tissue, followed by guide-wire injury 
of femoral artery. A fully understood relationship between adipokine, adipose 
tissue, ADSC and vascular remodeling would be of great importance for the 
future therapy in clinical medicine.  
 
4.9 Summary 
Obesity and vascular injury result in elevated leptin release in blood and the 
vessel wall, which can serve as a chemokine for Sca-1+ progenitor cell 
migration. During this process, the binding of leptin to its receptor (OBR) 
leads to the activation of signal pathways, e.g. STAT3-Rac1/Cdc42-ERK-FAK, 
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which are abrogated by OBR deficiency in animal models. The migratory 
response of Sca-1+ progenitor cells to increased leptin levels may be largely 
responsible for enhanced neointimal formation in injured vessels. These 
novel findings enhance our understanding of the mechanisms of 
obesity-related vascular diseases. The protective role of Lepr-/- Sca-1+ 
progenitors also suggests a possibility to specifically target the leptin receptor 
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